{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {
    "collapsed": true,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:06.954501200Z",
     "start_time": "2024-04-17T18:51:06.941309500Z"
    }
   },
   "outputs": [],
   "source": [
    "from langchain import hub\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain.vectorstores import Chroma\n",
    "from langchain_openai import ChatOpenAI, OpenAIEmbeddings\n",
    "from langchain.schema.output_parser import StrOutputParser\n",
    "from langchain.schema.runnable import RunnablePassthrough\n",
    "from langchain.prompts import ChatPromptTemplate\n",
    "\n",
    "import os\n",
    "from Bio import Entrez\n",
    "from datetime import datetime\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "outputs": [],
   "source": [
    "os.environ['OPENAI_API_KEY'] = \"Your_API\"\n",
    "llm = ChatOpenAI(model='gpt-4-1106-preview', temperature=1)\n"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:08.164705500Z",
     "start_time": "2024-04-17T18:51:06.952499900Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "outputs": [],
   "source": [
    "def get_entrez(keywords: list):\n",
    "    \"\"\"\n",
    "    This function takes in a list of keywords and searches the pubmed database for related articles\n",
    "    It would then return the abstract of articles found.\n",
    "    :param keywords:\n",
    "    :return: output\n",
    "    \"\"\"\n",
    "    # Set your email for PubMed requests (required)\n",
    "    Entrez.email = \"www.bahraam2002@gmail.com\"\n",
    "\n",
    "    # Keywords list to search in PubMed\n",
    "    keywords_list = keywords\n",
    "\n",
    "    # Combine keywords with OR operator for PubMed query. you can also use AND\n",
    "    keywords_query = ' OR '.join(keywords_list)\n",
    "\n",
    "    # Get today's date in for the text file's name (YYYY/MM/DD)\n",
    "    today_date = datetime.today().strftime('%Y-%m-%d')\n",
    "\n",
    "    # All you need to search is the keywords query\n",
    "    search_query = f'({keywords_query})'\n",
    "    search_results = Entrez.read(\n",
    "        Entrez.esearch(db=\"pubmed\", term=search_query, retmax=20, datetype=\"pdat\", reldate=90, usehistory=\"y\"))\n",
    "    webenv = search_results['WebEnv']\n",
    "    query_key = search_results['QueryKey']\n",
    "    id_list = search_results['IdList']\n",
    "    all_summaries = []\n",
    "    # Step 2: EFetch to retrieve titles based on the UIDs\n",
    "    for i in id_list:\n",
    "        fetch_handle = Entrez.efetch(db=\"pubmed\", id=i, rettype=\"abstract\", retmode=\"text\", webenv=webenv,\n",
    "                                     query_key=query_key)\n",
    "        fetch_content = fetch_handle.read()\n",
    "        all_summaries.append(fetch_content)  # Store title along with summary\n",
    "    output = ''.join(all_summaries)\n",
    "    return output"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:08.180803Z",
     "start_time": "2024-04-17T18:51:08.169208400Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "outputs": [],
   "source": [
    "def parse_keywords(output):\n",
    "    \"\"\"\n",
    "    Parses the output list from the llm so the output keywords could be seareched with get_entrez function\n",
    "    :param output:\n",
    "    :return: list(unique_keywords)\n",
    "    \"\"\"\n",
    "    # Initialize an empty set to store unique keywords\n",
    "    unique_keywords = set()\n",
    "\n",
    "    # Split the output into lines\n",
    "    lines = output['question'].strip().split('\\n')\n",
    "\n",
    "    # Iterate through each line\n",
    "    for line in lines:\n",
    "        # Extract keywords using regular expression\n",
    "        keywords = re.findall(r'\"([^\"]*)\"', line)\n",
    "\n",
    "        # Add keywords to the set\n",
    "        unique_keywords.update(keywords)\n",
    "\n",
    "    # Convert the set to a list and return\n",
    "    return list(unique_keywords)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:08.203911300Z",
     "start_time": "2024-04-17T18:51:08.183804600Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "outputs": [],
   "source": [
    "def collapse_list_of_lists(list_of_lists):\n",
    "    \"\"\"\n",
    "    Takes in a list of texts and joins them together\n",
    "    :param list_of_lists:\n",
    "    :return: content\n",
    "    \"\"\"\n",
    "    content = []\n",
    "    for l in list_of_lists:\n",
    "        content.append(\"\\n\\n\".join(l))\n",
    "    return \"\\n\\n\".join(content)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:08.211844700Z",
     "start_time": "2024-04-17T18:51:08.199171100Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "outputs": [],
   "source": [
    "def split_embeder_retrieve(text:str,question:str):\n",
    "    \"\"\"\n",
    "    Takes in a text and query, splits the text, embeds it and then seareches the database for a related content\n",
    "    :param text:\n",
    "    :param question:\n",
    "    :return: related documents\n",
    "    \"\"\"\n",
    "    splitter = RecursiveCharacterTextSplitter.from_tiktoken_encoder(chunk_size=300,chunk_overlap=50)\n",
    "    splits=splitter.create_documents([text])\n",
    "    documents = splitter.split_documents(splits)\n",
    "    ids = [str(i) for i in range(1, len(documents) + 1)]\n",
    "    vectorstore=Chroma.from_documents(documents=documents,embedding=OpenAIEmbeddings(),ids=ids)\n",
    "    print(documents)\n",
    "    print(len(vectorstore))\n",
    "    # retriever=vectorstore.as_retriever()\n",
    "    # retrieved=retriever.get_relevant_documents(question)\n",
    "    retrieved= vectorstore.similarity_search(question)\n",
    "    return retrieved"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:08.242090800Z",
     "start_time": "2024-04-17T18:51:08.215843900Z"
    }
   }
  },
  {
   "cell_type": "markdown",
   "source": [
    "Next we have a set of prompts that are first used to create keywords based on the user's question and then to answer with a small article."
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "outputs": [],
   "source": [
    "WRITER_SYSTEM_PROMPT = \"You are an AI critical thinker research assistant. Your sole purpose is to write well written, critically acclaimed, objective and structured reports on given text.\"  # noqa: E501\n",
    "# Report prompts from https://github.com/assafelovic/gpt-researcher/blob/master/gpt_researcher/master/prompts.py\n",
    "RESEARCH_REPORT_TEMPLATE = \"\"\"Information:\n",
    "--------\n",
    "{text}\n",
    "--------\n",
    "Using the above information, answer the following question or topic: \"{question}\" in a detailed report -- \\\n",
    "The report should focus on the answer to the question, should be well structured, informative, \\\n",
    "in depth, with facts and numbers if available and a minimum of 1,200 words.\n",
    "You should strive to write the report as long as you can using all relevant and necessary information provided.\n",
    "You must write the report with markdown syntax.\n",
    "You MUST determine your own concrete and valid opinion based on the given information. Do NOT deter to general and meaningless conclusions.\n",
    "Write all used source urls at the end of the report, and make sure to not add duplicated sources, but only one reference for each.\n",
    "You must write the report in apa format.\n",
    "Please do your best, this is very important to my career.\"\"\"  # noqa: E501\n",
    "\n",
    "prompt = ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        (\"system\", WRITER_SYSTEM_PROMPT),\n",
    "        (\"user\", RESEARCH_REPORT_TEMPLATE),\n",
    "    ]\n",
    ")"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:08.260031100Z",
     "start_time": "2024-04-17T18:51:08.247094900Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "outputs": [],
   "source": [
    "\n",
    "KEY_PROMPT = ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        (\n",
    "            \"user\",\n",
    "            \"extract 3 important keywords from  the following question: \"\n",
    "            \"{question}\\n\"\n",
    "            \"You must respond with a list of strings in the following format: \"\n",
    "            '[\"keywords1\", \"keywords2\",\"keywords3\"]'\n",
    "            \"for example if the question was What are the effects of protein intake on hypertrophy?\"\n",
    "            \"then you could return such a list:\"\n",
    "            '[\"muscle hypertrophy\",\"protein intake\"]',\n",
    "        ),\n",
    "    ]\n",
    ")"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:51:09.954729400Z",
     "start_time": "2024-04-17T18:51:09.937728800Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "outputs": [],
   "source": [
    "question=input('aks your question:\\n')\n"
   ],
   "metadata": {
    "collapsed": false
   }
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'question': '[\"exercise\", \"blood glucose\", \"affect\"]', 'text': '1. Chem Commun (Camb). 2024 Apr 17. doi: 10.1039/d4cc01111b. Online ahead of\\nprint.\\n\\nHalloysite-derived mesoporous silica with high ionic conductivity improves Li-S \\nbattery performance.\\n\\nAo R(1), Zhu Z(1), Zhang S(1)(2), Zhang Q(2)(3), Yan C(1), Tu F(4), Li T(4), Li \\nMG(5), Fu L(1)(2)(3), Tang A(1)(3), Yang H(1)(2)(3).\\n\\nAuthor information:\\n(1)Engineering Research Center of Nano-Geomaterials of Ministry of Education, \\nLaboratory of Advanced Mineral Materials, Faculty of Materials Science and \\nChemistry, China University of Geosciences, Wuhan 430074, China. \\ntangaidong@cug.edu.cn.\\n(2)College of Chemistry and Chemical Engineering, Central South University, \\nChangsha 410083, China. adtang@csu.edu.cn.\\n(3)Hunan Key Laboratory of Mineral Materials and Application, School of Minerals \\nProcessing and Bioengineering, Central South University, Changsha 410083, China. \\nhmyang@csu.edu.cn.\\n(4)Changsha Research Institute of Mining and Metallurgy Co. LTD., Changsha \\n410012, P. R. China.\\n(5)Division of Integrative Systems and Design, Department of Electronic and \\nComputer Engineering, The Hong Kong University of Science and Technology, Clear \\nWater Bay, Kowloon, Hong Kong SAR, P. R. China.\\n\\nThe slow Li+ transport rate in the thick sulfur cathode of the Li-S battery \\naffects its capacity and cycling performance. Herein, Fe-doped highly ordered \\nmesoporous silica material (Fe-HSBA-15) as a sulfur carrier of the Li-S battery \\nshows high ion conductivity (1.10 mS cm-1) and Li+ transference number (0.77). \\nThe Fe-HSBA-15/S cell has an initial capacity of up to 1216.7 mA h g-1 at 0.2C \\nand good stability. Impressively, at a high sulfur load of 4.34 mg cm-2, the \\nFe-HSBA-15/S cell still maintains an area specific capacity of 4.47 mA h cm-2 \\nafter 100 cycles. This is because Fe-HSBA-15 improves the Li+ diffusion behavior \\nthrough the ordered mesoporous structure. Theoretical calculations also \\nconfirmed that the doping of iron enhances the adsorption of polysulfides, \\nreduces the band gap and makes the catalytic activity stronger.\\n\\nDOI: 10.1039/d4cc01111b\\nPMID: 386305321. JMIR Med Educ. 2024 Apr 17;10:e50118. doi: 10.2196/50118.\\n\\nDevelopment of Web-Based Education Modules to Improve Carer Engagement in Cancer \\nCare: Design and User Experience Evaluation of the e-Triadic Oncology (eTRIO) \\nModules for Clinicians, Patients, and Carers.\\n\\nLaidsaar-Powell R(1)(2), Giunta S(1), Butow P(1)(2), Keast R(1), Koczwara \\nB(3)(4), Kay J(5), Jefford M(6), Turner S(7)(8), Saunders C(9), Schofield \\nP(6)(10)(11), Boyle F(8)(12), Yates P(13), White K(14), Miller A(15), Butt Z(1), \\nBonnaudet M(5)(16), Juraskova I(1)(2).\\n\\nAuthor information:\\n(1)Centre for Medical Psychology & Evidence-based Decision-making, School of \\nPsychology, The University of Sydney, Sydney, Australia.\\n(2)Psycho-Oncology Co-operative Research Group, The University of Sydney, \\nSydney, Australia.\\n(3)Flinders Medical Centre, Adelaide, Australia.\\n(4)College of Medicine and Public Health, Flinders University, Adelaide, \\nAustralia.\\n(5)School of Computer Science, The University of Sydney, Sydney, Australia.\\n(6)Health Services Research and Implementation Science, Peter MacCallum Cancer \\nCentre, Melbourne, Australia.\\n(7)Department of Radiation Oncology, Westmead Hospital, Westmead, Australia.\\n(8)Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.\\n(9)Department of Surgery, Royal Melbourne Hospital, University of Melbourne, \\nMelbourne, Australia.\\n(10)Department of Psychology and Iverson Health Innovation Research Institute, \\nSwinburne University, Melbourne, Australia.\\n(11)Sir Peter MacCallum Department of Oncology, The University of Melbourne, \\nMelbourne, Australia.\\n(12)Patricia Ritchie Centre for Cancer Care & Research, Mater Hospital, Sydney, \\nAustralia.\\n(13)Faculty of Health, Queensland University of Technology, Brisbane, Australia.\\n(14)Susan Wakil School of Nursing, The Daffodil Centre, The University of \\nSydney, a joint venture with Cancer Council New South Wales, Sydney, Australia.\\n(15)Cancer Council New South Wales, Sydney, Australia.\\n(16)School of Electrical Engineering and Computer Science, Kungliga Tekniska \\nhögskolan Royal Institute of Technology, Stockholm, Sweden.\\n\\nBACKGROUND: Carers often assume key roles in cancer care. However, many carers \\nreport feeling disempowered and ill-equipped to support patients. Our group \\npublished evidence-based guidelines (the Triadic Oncology [TRIO] Guidelines) to \\nimprove oncology clinician engagement with carers and the management of \\nchallenging situations involving carers.\\nOBJECTIVE: To facilitate implementation of the TRIO Guidelines in clinical \\npractice, we aimed to develop, iteratively refine, and conduct user testing of a \\nsuite of evidence-based and interactive web-based education modules for oncology \\nclinicians (e-Triadic Oncology [eTRIO]), patients with cancer, and carers (eTRIO \\nfor Patients and Carers [eTRIO-pc]). These were designed to improve carer \\ninvolvement, communication, and shared decision-making in the cancer management \\nsetting.\\nMETHODS: The eTRIO education modules were based on extensive research, including \\nsystematic reviews, qualitative interviews, and consultation analyses. Guided by \\nthe person-based approach, module content and design were reviewed by an expert \\nadvisory group comprising academic and clinical experts (n=13) and consumers \\n(n=5); content and design were continuously and iteratively refined. User \\nexperience testing (including \"think-aloud\" interviews and administration of the \\nSystem Usability Scale [SUS]) of the modules was completed by additional \\nclinicians (n=5), patients (n=3), and carers (n=3).\\nRESULTS: The final clinician module comprises 14 sections, requires \\napproximately 1.5 to 2 hours to complete, and covers topics such as \\ncarer-inclusive communication and practices; supporting carer needs; and \\nmanaging carer dominance, anger, and conflicting patient-carer wishes. The \\nusability of the module was rated by 5 clinicians, with a mean SUS score of 75 \\n(SD 5.3), which is interpreted as good. Clinicians often desired information in \\na concise format, divided into small \"snackable\" sections that could be easily \\nrecommenced if they were interrupted. The carer module features 11 sections; \\nrequires approximately 1.5 hours to complete; and includes topics such as the \\nimportance of carers, carer roles during consultations, and advocating for the \\npatient. The patient module is an adaptation of the relevant carer module \\nsections, comprising 7 sections and requiring 1 hour to complete. The average \\nSUS score as rated by 6 patients and carers was 78 (SD 16.2), which is \\ninterpreted as good. Interactive activities, clinical vignette videos, and \\nreflective learning exercises are incorporated into all modules. Patient and \\ncarer consumer advisers advocated for empathetic content and tone throughout \\ntheir modules, with an easy-to-read and navigable module interface.\\nCONCLUSIONS: The eTRIO suite of modules were rigorously developed using a \\nperson-based design methodology to meet the unique information needs and \\nlearning requirements of clinicians, patients, and carers, with the goal of \\nimproving effective and supportive carer involvement in cancer consultations and \\ncancer care.\\n\\n©Rebekah Laidsaar-Powell, Sarah Giunta, Phyllis Butow, Rachael Keast, Bogda \\nKoczwara, Judy Kay, Michael Jefford, Sandra Turner, Christobel Saunders, \\nPenelope Schofield, Frances Boyle, Patsy Yates, Kate White, Annie Miller, Zoe \\nButt, Melanie Bonnaudet, Ilona Juraskova. Originally published in JMIR Medical \\nEducation (https://mededu.jmir.org), 17.04.2024.\\n\\nDOI: 10.2196/50118\\nPMID: 386305311. JMIR Hum Factors. 2024 Apr 17;11:e54172. doi: 10.2196/54172.\\n\\nA Smartphone App to Support Self-Management for People Living With Sjögren\\'s \\nSyndrome: Qualitative Co-Design Workshops.\\n\\nMcCallum C(#)(1), Campbell M(#)(2), Vines J(3), Rapley T(4), Ellis J(5), Deary \\nV(5), Hackett K(4).\\n\\nAuthor information:\\n(1)Faculty of Engineering, University of Bristol, Bristol, United Kingdom.\\n(2)Institute for Collective Place Leadership, Teesside University, \\nMiddlesbrough, United Kingdom.\\n(3)School of Informatics, University of Edinburgh, Edinburgh, United Kingdom.\\n(4)Department of Social Work, Education and Community Wellbeing, Northumbria \\nUniversity, Newcastle upon Tyne, United Kingdom.\\n(5)Department of Psychology, Northumbria University, Newcastle upon Tyne, United \\nKingdom.\\n(#)Contributed equally\\n\\nBACKGROUND: Sjögren\\'s syndrome (SS) is the second most common autoimmune \\nrheumatic disease, and the range of symptoms includes fatigue, dryness, sleep \\ndisturbances, and pain. Smartphone apps may help deliver a variety of cognitive \\nand behavioral techniques to support self-management in SS. However, app-based \\ninterventions must be carefully designed to promote engagement and motivate \\nbehavior change.\\nOBJECTIVE: We aimed to explore self-management approaches and challenges \\nexperienced by people living with SS and produce a corresponding set of design \\nrecommendations that inform the design of an engaging, motivating, and \\nevidence-based self-management app for those living with SS.\\nMETHODS: We conducted a series of 8 co-design workshops and an additional 3 \\ninterviews with participants who were unable to attend a workshop. These were \\naudio recorded, transcribed, and initially thematically analyzed using an \\ninductive approach. Then, the themes were mapped to the Self-Determination \\nTheory domains of competency, autonomy, and relatedness.\\nRESULTS: Participants experienced a considerable demand in the daily work \\nrequired in self-managing their SS. The condition demanded unrelenting, \\nfluctuating, and unpredictable mental, physical, and social efforts. \\nParticipants used a wide variety of techniques to self-manage their symptoms; \\nhowever, their sense of competency was undermined by the complexity and \\ninterconnected nature of their symptoms and affected by interactions with \\nothers. The daily contexts in which this labor was occurring revealed ample \\nopportunities to use digital health aids. The lived experience of participants \\nshowed that the constructs of competency, autonomy, and relatedness existed in a \\ncomplex equilibrium with each other. Sometimes, they were disrupted by tensions, \\nwhereas on other occasions, they worked together harmoniously.\\nCONCLUSIONS: An SS self-management app needs to recognize the complexity and \\noverlap of symptoms and the complexities of managing the condition in daily \\nlife. Identifying techniques that target several symptoms simultaneously may \\nprevent users from becoming overwhelmed. Including techniques that support \\nassertiveness and communication with others about the condition, its symptoms, \\nand users\\' limitations may support users in their interactions with others and \\nimprove engagement in symptom management strategies.\\xa0For digital health aids \\n(such as self-management apps) to provide meaningful support, they should be \\ndesigned according to human needs such as competence, autonomy, and relatedness. \\nHowever, the complexities among the 3 Self-Determination Theory constructs \\nshould be carefully considered, as they present both design difficulties and \\nopportunities.\\n\\n©Claire McCallum, Miglena Campbell, John Vines, Tim Rapley, Jason Ellis, Vincent \\nDeary, Katie Hackett. Originally published in JMIR Human Factors \\n(https://humanfactors.jmir.org), 17.04.2024.\\n\\nDOI: 10.2196/54172\\nPMID: 386305301. JMIR Public Health Surveill. 2024 Apr 17;10:e50996. doi: 10.2196/50996.\\n\\nAssociation Between Frequency of Muscle-Strengthening Exercise and Depression \\nSymptoms Among Middle and High School Students: Cross-Sectional Survey Study.\\n\\nWang H(1), Du H(2)(3), Guan Y(1), Zhong J(1), Li N(1), Pan J(1), Yu M(1).\\n\\nAuthor information:\\n(1)Department of Noncommunicable Disease Control and Prevention, Zhejiang \\nProvincial Center for Disease Control and Prevention, Hangzhou, China.\\n(2)Medical Research Council Population Health Research Unit, Nuffield Department \\nof Population Health, University of Oxford, Oxford, United Kingdom.\\n(3)Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield \\nDepartment of Population Health, University of Oxford, Oxford, United Kingdom.\\n\\nBACKGROUND: Existing literature on the association between the frequency of \\nmuscle-strengthening exercise (MSE) and depression among adolescents is limited \\nand contradictory.\\nOBJECTIVE: This study aimed to elucidate the association of MSE frequency with \\ndepression symptoms among middle and high school students in China.\\nMETHODS: A total of 27,070 students in grades 7-12 from 376 middle and high \\nschools were surveyed using an anonymous self-administered questionnaire between \\nApril and June 2022. Information on engaging in MSE was self-reported, and \\ndepression symptoms were assessed using the Patient Health Questionnaire-9 \\n(PHQ-9). Poisson regression was used to examine the association between MSE \\nfrequency and depression symptoms.\\nRESULTS: Among the 27,006 eligible students, 51.6% (n=13,933) were boys, and the \\nmean age was 15.6 (SD 1.7) years. The overall prevalence of meeting MSE \\nrecommendations (ie, engaging in MSE ≥3 days/week) was 34.6% (95% CI \\n32.6%-36.6%; n=9145); the prevalence was higher in boys (43.8%, 95% CI \\n41.8%-45.8%; 6067/13,933) than in girls (24.3%, 95% CI 22%-26.6%; 3078/13,073; \\nP<.001). A total of 5882 (21.8%) students reported having depression symptoms. \\nAfter adjustment for sociodemographic status, lifestyle factors, academic \\nperformance, and experience of physical fighting, compared to students who did \\nnot engage in MSE, the prevalence ratios (PRs) for depression symptoms were 0.98 \\n(95% CI 0.97-0.99) for those engaging in MSE once a week, 0.95 (95% CI \\n0.93-0.97) for 2 days/week, 0.93 (95% CI 0.90-0.96) for 3 days/week, 0.90 (95% \\nCI 0.87-0.94) for 4 days/week, 0.88 (95% CI 0.84-0.93) for 5 days/week, 0.86 \\n(95% CI 0.81-0.92) for 6 days/week, and 0.84 (95% CI 0.78-0.90) for 7 days/week, \\nrespectively.\\nCONCLUSIONS: The overall prevalence of meeting MSE recommendations among Chinese \\nadolescents is low. The frequency of MSE was inversely associated with \\ndepression symptoms.\\n\\n©Hao Wang, Huaidong Du, Yunqi Guan, Jieming Zhong, Na Li, Jin Pan, Min Yu. \\nOriginally published in JMIR Public Health and Surveillance \\n(https://publichealth.jmir.org), 17.04.2024.\\n\\nDOI: 10.2196/50996\\nPMID: 386305291. JMIR Res Protoc. 2024 Apr 17;13:e54406. doi: 10.2196/54406.\\n\\nPsychotherapy for Ketamine\\'s Enhanced Durability in Chronic Neuropathic Pain: \\nProtocol for a Pilot Randomized Controlled Trial.\\n\\nGoel A(#)(1)(2), Kapoor B(#)(1)(3), Chan H(4), Ladha K(1)(2)(5), Katz \\nJ(2)(6)(7)(8)(9), Clarke H(2)(7)(8), Pazmino-Canizares J(1), Thomas Z(1), Philip \\nK(1)(4), Mattina G(1), Ritvo P(6)(9).\\n\\nAuthor information:\\n(1)Department of Anesthesia and Pain Medicine, St Michael\\'s Hospital, Toronto, \\nON, Canada.\\n(2)Department of Anesthesiology and Pain Medicine, University of Toronto, \\nToronto, ON, Canada.\\n(3)Department of Medicine, Royal College of Surgeons in Ireland, Dublin, \\nIreland.\\n(4)Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.\\n(5)Institute of Health Policy, Management and Evaluation, University of Toronto, \\nToronto, ON, Canada.\\n(6)Department of Psychology, York University, Toronto, ON, Canada.\\n(7)Department of Anesthesia and Pain Management, Toronto General Hospital, \\nToronto, ON, Canada.\\n(8)Centre for the Study of Pain, University of Toronto, Toronto, ON, Canada.\\n(9)School of Kinesiology and Health Sciences, York University, Toronto, ON, \\nCanada.\\n(#)Contributed equally\\n\\nBACKGROUND: Chronic pain affects approximately 8 million Canadians (~20%), \\nimpacting their physical and mental health while burdening the health care \\nsystem with costs of upwards of US $60 billion a year. Indeed, patients are \\noften trialed on numerous medications over several years without reductions to \\ntheir symptoms. Therefore, there is an urgent need to identify new therapies for \\nchronic pain to improve patients\\' quality of life, increase the availability of \\ntreatment options, and reduce the burden on the health care system.\\nOBJECTIVE: The primary objective of this study is to examine the feasibility of \\na parallel 3-arm pilot randomized controlled trial whereby patients are \\nrandomized to either intravenous ketamine alone, cognitive behavioral therapy \\n(CBT) and mindfulness meditation (MM) training (CBT/MM), or the combination of \\nintravenous ketamine and CBT/MM. The secondary outcome is to assess the \\ndurability and efficacy of combination intravenous ketamine and CBT/MM for \\ntreatment of chronic pain as compared to CBT/MM or intravenous ketamine alone \\n(assessed at week 20 of the study).\\nMETHODS: This is a single-center, 16-week, 3-arm pilot study that will take \\nplace at the Chronic Pain Clinic at St. Michael\\'s Hospital, Toronto, Ontario, \\nwhich receives 1000 referrals per year. Patients will be enrolled in the study \\nfor a total of 20 weeks. Participants who are allocated CBT/MM therapy will \\nreceive remote weekly psychotherapy from week 1 to week 16, inclusive of health \\ncoaching administered through the NexJ Health Inc (NexJ Health) platform. \\nPatients who are allocated ketamine-infusion therapy will receive monthly \\nketamine infusion treatments on weeks 2, 7, and 12. Patients who are allocated \\nketamine+CBT/MM will receive weekly psychotherapy from weeks 1 to 16, inclusive, \\nas well as ketamine infusion treatments on weeks 2, 7, and 12. We will be \\nassessing recruitment rates, consent rates, withdrawal rates, adherence, missing \\ndata, and adverse events as pilot outcome measures. Secondary clinical outcomes \\ninclude changes relative to baseline in pain intensity and pain interference.\\nRESULTS: As of November 1, 2023, the recruitment process has not been initiated. \\nGiven the recruitment, consent, and intervention target of 30 participants for \\nthis feasibility study, with each patient undergoing monitoring and treatments \\nfor a course of 20 weeks, we expect to complete the study by December 2025.\\nCONCLUSIONS: This study assesses the feasibility of conducting a 3-arm \\nrandomized controlled trial to examine the effects of ketamine administration \\nwith the concurrent use of CBT/MM in a population with chronic neuropathic pain. \\nThe results of this pilot randomized controlled trial will inform the \\ndevelopment of a larger-scale randomized controlled trial. Future studies will \\nbe aimed at including a sufficiently powered sample that will inform decisions \\nabout optimal treatment calibration and treatment effect duration.\\nTRIAL REGISTRATION: ClinicalTrials.gov NCT05639322; \\nhttps://classic.clinicaltrials.gov/ct2/show/NCT05639322.\\nINTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/54406.\\n\\n©Akash Goel, Bhavya Kapoor, Hillary Chan, Karim Ladha, Joel Katz, Hance Clarke, \\nJanneth Pazmino-Canizares, Zaaria Thomas, Kaylyssa Philip, Gabriella Mattina, \\nPaul Ritvo. Originally published in JMIR Research Protocols \\n(https://www.researchprotocols.org), 17.04.2024.\\n\\nDOI: 10.2196/54406\\nPMID: 386305241. Mol Biol Cell. 2024 Apr 17:mbcE24020093. doi: 10.1091/mbc.E24-02-0093. Online \\nahead of print.\\n\\nA Methodology for Specific Disruption of Microtubule Polymerization into \\nDendritic Spines.\\n\\nHolland ED(1), Miller HL(1), Millette MM(2), Taylor RJ(2), Drucker GL(2), Dent \\nEW(2).\\n\\nAuthor information:\\n(1)Neuroscience Training Program, University of Wisconsin-Madison, WI 53705.\\n(2)Department of Neuroscience, School of Medicine and Public Health, Madison, WI \\n53705.\\n\\nDendritic spines, the mushroom-shaped extensions along dendritic shafts of \\nexcitatory neurons, are critical for synaptic function and are one of the first \\nneuronal structures disrupted in neurodevelopmental and neurodegenerative \\ndiseases. Microtubule (MT) polymerization into dendritic spines is an \\nactivity-dependent process capable of affecting spine shape and function. \\nStudies have shown that MT polymerization into spines occurs specifically in \\nspines undergoing plastic changes. However, discerning the function of MT \\ninvasion of dendritic spines requires the specific inhibition of MT \\npolymerization into spines, while leaving MT dynamics in the dendritic shaft, \\nsynaptically connected axons and associated glial cells intact. This is not \\npossible with the unrestricted, bath application of pharmacological compounds. \\nTo specifically disrupt MT entry into spines we coupled a MT elimination domain \\n(MTED) from the Efa6 protein to the actin filament-binding peptide LifeAct. \\nLifeAct was chosen because actin filaments are highly concentrated in spines and \\nare necessary for MT invasions. Temporally controlled expression of this \\nLifeAct-MTED construct inhibits MT entry into dendritic spines, while preserving \\ntypical MT dynamics in the dendrite shaft. Expression of this construct will \\nallow for the determination of the function of MT invasion of spines and more \\nbroadly, to discern how MT-actin interactions affect cellular processes.\\n\\nDOI: 10.1091/mbc.E24-02-0093\\nPMID: 386305191. Analyst. 2024 Apr 17. doi: 10.1039/d4an00181h. Online ahead of print.\\n\\nThermal evaporation as sample preparation for silver-assisted laser \\ndesorption/ionization mass spectrometry imaging of cholesterol in amyloid \\ntissues.\\n\\nStrnad Š(1), Vrkoslav V(1), Mengr A(1), Fabián O(2)(3), Rybáček J(1), Kubánek \\nM(2), Melenovský V(2), Maletínská L(1), Cvačka J(1).\\n\\nAuthor information:\\n(1)Institute of Organic Chemistry and Biochemistry of the Czech Academy of \\nSciences, 166 10, Prague, Czech Republic. vladimir.vrkoslav@uochb.cas.cz.\\n(2)Institute for Clinical and Experimental Medicine, 140 21, Prague, Czech \\nRepublic.\\n(3)Department of Pathology and Molecular Medicine, Third Faculty of Medicine, \\nCharles University and Thomayer Hospital, 140 59, Prague, Czech Republic.\\n\\nCholesterol plays an important biological role in the body, and its disruption \\nin homeostasis and synthesis has been implicated in several diseases. Mapping \\nthe locations of cholesterol is crucial for gaining a better understanding of \\nthese conditions. Silver deposition has proven to be an effective method for \\nanalyzing cholesterol using mass spectrometry imaging (MSI). We optimized and \\nevaluated thermal evaporation as an alternative deposition technique to \\nsputtering for silver deposition in MSI of cholesterol. A silver layer with a \\nthickness of 6 nm provided an optimal combination of cholesterol signal \\nintensity and mass resolution. The deposition of an ultrathin nanofilm of silver \\nenabled high-resolution MSI with a pixel size of 10 μm. We used this optimized \\nmethod to visualize the distribution of cholesterol in the senile plaques in the \\nbrains of APP/PS1 mice, a model that resembles Alzheimer\\'s disease pathology. We \\nfound that cholesterol was evenly distributed across the frontal cortex tissue, \\nwith no evidence of plaque-like accumulation. Additionally, we investigated the \\npresence and distribution of cholesterol in myocardial sections of a human heart \\naffected by wild-type ATTR amyloidosis. We identified the presence of \\ncholesterol in areas with amyloid deposition, but complete colocalization was \\nnot observed.\\n\\nDOI: 10.1039/d4an00181h\\nPMID: 386305031. JAMA Netw Open. 2024 Apr 1;7(4):e246858. doi:\\n10.1001/jamanetworkopen.2024.6858.\\n\\nClinician Burnout and Effectiveness of Guideline-Recommended Psychotherapies.\\n\\nSayer NA(1)(2)(3), Kaplan A(1)(2), Nelson DB(1)(2), Wiltsey Stirman S(4)(5), \\nRosen CS(4)(5).\\n\\nAuthor information:\\n(1)Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care \\nSystem, Minneapolis, Minnesota.\\n(2)Department of Medicine, University of Minnesota, Minneapolis.\\n(3)Department of Psychiatry and Behavioral Sciences, University of Minnesota, \\nMinneapolis.\\n(4)National Center for Posttraumatic Stress Disorder, Dissemination and Training \\nDivision at the Veterans Affairs Palo Alto Health Care System, Palo Alto, \\nCalifornia.\\n(5)Department of Psychiatry and Behavioral Sciences, Stanford University School \\nof Medicine, Stanford, California.\\n\\nIMPORTANCE: Clinician burnout has been associated with clinician outcomes, but \\nthe association with patient outcomes remains unclear.\\nOBJECTIVE: To evaluate the association between clinician burnout and the \\noutcomes of patients receiving of guideline-recommended trauma-focused \\npsychotherapies for posttraumatic stress disorder (PTSD).\\nDESIGN, SETTING, AND PARTICIPANTS: This cohort study was set at the US Veterans \\nAffairs Health Care System and included licensed therapists who provided \\ntrauma-focused psychotherapies and responded to an online survey between May 2 \\nand October 8, 2019, and their patients who initiated a trauma-focused therapy \\nduring the following year. Patient data were collected through December 31, \\n2020. Data were analyzed from May to September 2023.\\nEXPOSURES: Therapists completing the survey reported burnout with a 5-point \\nvalidated measure taken from the Physician Worklife Study. Burnout was defined \\nas scores of 3 or more.\\nMAIN OUTCOMES AND MEASURES: The primary outcome was patients\\' clinically \\nmeaningful improvement in PTSD symptoms according to the PTSD Checklist for the \\nDiagnostic and Statistical Manual of Mental Disorders (Fifth Edition). Patient \\ndropout, therapist adherence, and session spacing was assessed through \\nelectronic health records. Multivariable random-effects logistic regression \\nexamined the association of therapist burnout and clinically meaningful \\nimprovement, adjusted for case-mix.\\nRESULTS: In this study, 165 of 180 (91.7%) therapists (89 [53.9%] female) \\ncompleted the burnout measure and provided trauma-focused psychotherapies to \\n1268 patients (961 [75.8%] male) with outcome data. Fifty-eight (35.2%) \\ntherapists endorsed burnout. One third of patients (431 [34.0%]) met criterion \\nfor clinically meaningful improvement. Clinically meaningful improvement in PTSD \\nsymptoms was experienced by 120 (28.3%) of the 424 patients seen by therapists \\nwho reported burnout and 311 (36.8%) of the 844 patients seen by therapists \\nwithout burnout. Burnout was associated with lower odds of clinically meaningful \\nimprovement (adjusted odds ratio [OR],0.63; 95% CI, 0.48-0.85). The odds of \\nclinically meaningful improvement were reduced for patients who dropped out (OR, \\n0.15; 95% CI, 0.11-0.20) and had greater session spacing (OR, 0.80; 95% CI, \\n0.70-0.92). Therapist adherence was not associated with therapy effectiveness. \\nAdjusting for dropout or session spacing did not meaningfully alter the \\nmagnitude of the association between burnout and clinically meaningful \\nimprovement.\\nCONCLUSIONS AND RELEVANCE: In this prospective cohort study, therapist burnout \\nwas associated with reduced effectiveness of trauma-focused psychotherapies. \\nStudying when and how burnout affects patient outcomes may inform workplace \\ninterventions.\\n\\nDOI: 10.1001/jamanetworkopen.2024.6858\\nPMID: 386304771. JAMA Surg. 2024 Apr 17. doi: 10.1001/jamasurg.2024.0718. Online ahead of\\nprint.\\n\\nPlacebo Control and Blinding in Randomized Trials of Procedural Interventions: A \\nSystematic Review and Meta-Regression.\\n\\nRajkumar CA(1), Thomas KE(2), Foley M(1), Ganesananthan S(1), Evans H(1), \\nSimader F(1), Syam S(1), Nour D(3), Beattie C(4), Khan C(1), Reddy RK(1), \\nAhmed-Jushuf F(1), Francis DP(1), Shun-Shin M(1), Al-Lamee RK(1).\\n\\nAuthor information:\\n(1)National Heart and Lung Institute, Imperial College London, London, United \\nKingdom.\\n(2)Division of Cardiovascular Medicine, University of Oxford, Oxford, United \\nKingdom.\\n(3)Royal North Shore Hospital, Sydney, New South Wales, Australia.\\n(4)Royal Free London National Health Service Foundation Trust, London, United \\nKingdom.\\n\\nIMPORTANCE: Unlike medications, procedural interventions are rarely trialed \\nagainst placebo prior to becoming accepted in clinical practice. When \\nplacebo-controlled trials are eventually conducted, procedural interventions may \\nbe less effective than previously believed.\\nOBJECTIVE: To investigate the importance of including a placebo arm in trials of \\nsurgical and interventional procedures by comparing effect sizes from trials of \\nthe same procedure that do and do not include a placebo arm.\\nDATA SOURCES: Searches of MEDLINE and Embase identified all placebo-controlled \\ntrials for procedural interventions in any specialty of medicine and surgery \\nfrom inception to March 31, 2019. A secondary search identified randomized \\nclinical trials assessing the same intervention, condition, and end point but \\nwithout a placebo arm for paired comparison.\\nSTUDY SELECTION: Placebo-controlled trials of anatomically site-specific \\nprocedures requiring skin incision or endoscopic techniques were eligible for \\ninclusion; these were then matched to trials without placebo control that fell \\nwithin prespecified limits of heterogeneity.\\nDATA EXTRACTION AND SYNTHESIS: Random-effects meta-regression, with placebo and \\nblinding as a fixed effect and intervention and end point grouping as random \\neffects, was used to calculate the impact of placebo control for each end point. \\nData were analyzed from March 2019 to March 2020.\\nMAIN OUTCOMES AND MEASURES: End points were examined in prespecified subgroups: \\npatient-reported or health care professional-assessed outcomes, quality of life, \\npain, blood pressure, exercise-related outcomes, recurrent bleeding, and \\nall-cause mortality.\\nRESULTS: Ninety-seven end points were matched from 72 blinded, \\nplacebo-controlled trials (hereafter, blinded) and 55 unblinded trials without \\nplacebo control (hereafter, unblinded), including 111\\u202f500 individual patient end \\npoints. Unblinded trials had larger standardized effect sizes than blinded \\ntrials for exercise-related outcomes (standardized mean difference [SMD], 0.59; \\n95% CI, 0.29 to 0.89; P\\u2009<\\u2009.001) and quality-of-life (SMD, 0.32; 95% CI, 0.11 to \\n0.53; P\\u2009=\\u2009.003) and health care professional-assessed end points (SMD, 0.40; 95% \\nCI, 0.18 to 0.61; P\\u2009<\\u2009.001). The placebo effect accounted for 88.1%, 55.2%, and \\n61.3% of the observed unblinded effect size for these end points, respectively. \\nThere was no significant difference between unblinded and blinded trials for \\npatient-reported end points (SMD, 0.31; 95% CI, -0.02 to 0.64; P\\u2009=\\u2009.07), blood \\npressure (SMD, 0.26; 95% CI, -0.10 to 0.62; P\\u2009=\\u2009.15), all-cause mortality (odds \\nratio [OR], 0.23; 95% CI, -0.26 to 0.72; P\\u2009=\\u2009.36), pain (SMD, 0.03; 95% CI, \\n-0.52 to 0.57; P\\u2009=\\u2009.91), or recurrent bleeding events (OR, -0.12; 95% CI, -1.11 \\nto 0.88; P\\u2009=\\u2009.88).\\nCONCLUSIONS AND RELEVANCE: The magnitude of the placebo effect found in this \\nsystematic review and meta-regression was dependent on the end point. Placebo \\ncontrol in trials of procedural interventions had the greatest impact on \\nexercise-related, quality-of-life, and health care professional-assessed end \\npoints. Randomized clinical trials of procedural interventions may consider \\nplacebo control accordingly.\\n\\nDOI: 10.1001/jamasurg.2024.0718\\nPMID: 386304621. Vet Res Commun. 2024 Apr 17. doi: 10.1007/s11259-024-10378-0. Online ahead of \\nprint.\\n\\nThe vehicle of administration, feed or water, and prandial state influence the \\noral bioavailability of amoxicillin in piglets.\\n\\nDecundo JM(1)(2), Dieguez SN(3)(4)(5), Martínez G(3)(4), Amanto FA(6), Gaudio \\nDSP(3)(4), Soraci AL(3)(4).\\n\\nAuthor information:\\n(1)Laboratorio de Toxicología, Departamento de Fisiopatología, Facultad de \\nCiencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos \\nAires, Tandil, Argentina. jdecundo@vet.unicen.edu.ar.\\n(2)Facultad de Ciencias Veterinarias, Centro de Investigación Veterinaria de \\nTandil (CIVETAN, UNCPBA-CICPBA-CONICET), Paraje Arroyo Seco s/n, Campus \\nUniversitario, CP (7000), Tandil, Buenos Aires, Argentina. \\njdecundo@vet.unicen.edu.ar.\\n(3)Laboratorio de Toxicología, Departamento de Fisiopatología, Facultad de \\nCiencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos \\nAires, Tandil, Argentina.\\n(4)Facultad de Ciencias Veterinarias, Centro de Investigación Veterinaria de \\nTandil (CIVETAN, UNCPBA-CICPBA-CONICET), Paraje Arroyo Seco s/n, Campus \\nUniversitario, CP (7000), Tandil, Buenos Aires, Argentina.\\n(5)Comisión de Investigaciones Científicas de la Provincia de Buenos Aires \\n(CIC-PBA), Tandil, Argentina.\\n(6)Área de Producción Porcina, Departamento de Producción Animal, Facultad de \\nCiencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos \\nAires, Tandil, Argentina.\\n\\nFeed and water components may interact with drugs and affect their dissolution \\nand bioavailability. The impact of the vehicle of administration (feed and \\nwater) and the prandial condition of weaner piglets on amoxicillin´s oral \\nbioavailability was evaluated. First, amoxicillin\\'s in vitro dissolution and \\nstability in purified, soft, and hard water, as well as release kinetics from \\nfeed in simulated gastric and intestinal media were assessed. Then, \\npharmacokinetic parameters and bioavailability were determined in fasted and fed \\npigs using soft water, hard water, or feed as vehicles of administration \\nfollowing a balanced incomplete block design. Amoxicillin showed similar \\ndissolution profiles in soft and hard water, distinct from the dissolution \\nprofile obtained with purified water. Complete dissolution was only achieved in \\npurified water, and merely reached 50% in soft or hard water. Once dissolved, \\nantibiotic concentrations decreased by around 20% after 24\\xa0h in all solutions. \\nKorsmeyer-Peppas model best described amoxicillin release from feed in simulated \\ngastric and intestinal media. Feed considerably reduced antibiotic dissolution \\nin both simulated media. In vivo, amoxicillin exhibited significantly higher \\nbioavailability when delivered via water to fasted than to fed animals, while \\nin-feed administration yielded the lowest values. All treatments showed a \\nsimilar rate of drug absorption. In conclusion, we demonstrated that water and \\nfeed components, as well as feed present in gastrointestinal tract of piglets \\ndecrease amoxicillin´s oral bioavailability. Therefore, the use of oral \\namoxicillin as a broad-spectrum antibiotic to treat systemic infections in pigs \\nshould be thoroughly revised.\\n\\n© 2024. The Author(s), under exclusive licence to Springer Nature B.V.\\n\\nDOI: 10.1007/s11259-024-10378-0\\nPMID: 386304261. Vet Res Commun. 2024 Apr 17. doi: 10.1007/s11259-024-10370-8. Online ahead of \\nprint.\\n\\nA case report of acute claudication due to vena cava thromboembolism in a dog \\nnaturally infected with Leishmania Infantum.\\n\\nCalvo-Sánchez N(#)(1), Gómez Á(#)(1), Pérez E(1), Borobia M(2), Luján L(1), \\nFernández A(1)(3)(4), Villanueva-Saz S(5)(6)(7), Verde M(1)(3)(4), Marteles \\nD(1)(3).\\n\\nAuthor information:\\n(1)Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain.\\n(2)Veterinary Faculty, Veterinary Teaching Hospital, University of Zaragoza, \\nZaragoza, 50013, Spain.\\n(3)Clinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain.\\n(4)Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), \\nZaragoza, 50013, Spain.\\n(5)Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain. svs@unizar.es.\\n(6)Clinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain. svs@unizar.es.\\n(7)Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), \\nZaragoza, 50013, Spain. svs@unizar.es.\\n(#)Contributed equally\\n\\nCanine leishmaniosis is a vector-borne disease caused by Leishmania infantum, \\nand clinical manifestations of infection range from absent or severe to fatal \\nand result from immune-mediated mechanisms. In dogs, the most common clinical \\nsigns of leishmaniosis include skin lesions and lymphadenomegaly. However, the \\npresence of other nontypical signs has been described, and diagnosing these \\ncases can be challenging. The aim of the present short communication was to \\ndescribe the impact of the formation of circulating immunocomplexes due to L. \\ninfantum in a dog with leishmaniosis affected by a massive venous thrombus of \\nthe caudal vena cava and external iliac veins. On admission, the dog presented \\nbilateral cutaneous vasculopathy of the thigh and renal disease due to L. \\ninfantum infection. Two weeks after starting anti-Leishmania treatment based on \\nmeglumine antimoniate and allopurinol administration, the animal developed acute \\nclaudication of the hind limbs with the presence of a thrombus in the caudal \\nvena cava and the external iliac veins and a high level of circulating \\nimmunocomplexes detected by enzyme-linked immunosorbent assay. Exacerbation of \\nthe humoral immune response, along with deposition of circulating immune \\ncomplexes in the tissues and the concurrent presence of kidney and liver damage, \\nmight have contributed to an imbalance in haemostasis in this patient. Future \\nstudies should evaluate and analyse the pathological mechanisms contributing to \\nthrombosis in dogs with leishmaniosis.\\n\\n© 2024. The Author(s).\\n\\nDOI: 10.1007/s11259-024-10370-8\\nPMID: 386304251. J Clin Immunol. 2024 Apr 17;44(4):101. doi: 10.1007/s10875-024-01709-6.\\n\\nInborn Errors of Immunity in Jordan: First Report from a Tertiary Referral \\nCenter.\\n\\nAlzyoud R(1), Alsuweiti M(2), Maaitah H(2), Aladaileh B(2), Noubani M(2), Nsour \\nH(2).\\n\\nAuthor information:\\n(1)Pediatric Allergy, Immunology, and Rheumatology Division, Queen Rania \\nChildren\\'s Hospital, Jordanian Royal Medical Service, Amman, Jordan. \\nraedalzyoud@gmail.com.\\n(2)Pediatric Allergy, Immunology, and Rheumatology Division, Queen Rania \\nChildren\\'s Hospital, Jordanian Royal Medical Service, Amman, Jordan.\\n\\nPURPOSE: Inborn errors of immunity (IEI) are a heterogeneous group of diseases \\nwith variable clinical phenotypes. This study was conducted to describe the \\nepidemiology, clinical presentations, treatment, and outcome of IEI in Jordanian \\nchildren.\\nMETHODS: A retrospective data analysis was conducted for children under 15 years \\ndiagnosed with IEI from the pediatric Allergy, Immunology, and Rheumatology \\nDivision-based registry at Queen Rania Children\\'s Hospital, Amman, Jordan, \\nbetween 2010 and 2022.\\nRESULTS: A total of 467 patients, 263 (56.3%) males and 204 (43.7%) females, \\nwere diagnosed with IEI. The mean age at symptom onset was 18 months (1 week to \\n144 months), a positive family history of IEI was reported in 43.5%, and the \\nconsanguinity rate was 47.9%. The most common IEI category was \\nimmunodeficiencies affecting cellular and humoral immunity at 33.2%, followed by \\npredominantly antibody deficiencies at 16.9%. The overall median diagnostic \\ndelay (range) was 6 (0-135) months; patients with a positive family history of \\nIEI had a statistically significant shorter diagnostic delay. Pulmonary and \\ngastrointestinal clinical features were the most common at 55.2% and 45.6%, \\nrespectively. The overall mortality was 33.2%; the highest rate was reported in \\nsevere combined immunodeficiency at 56.2%.\\nCONCLUSIONS: The high minimal estimated IEI prevalence at 16.2/100,000 Jordanian \\nchildren compared to the regional and worldwide data, with the diversities in \\nclinical presentation and distribution of IEI categories in our cohort point to \\nunique features of IEI in Jordanian children, call for national registry \\nestablishment, regional and international collaborative networks.\\n\\n© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s10875-024-01709-6\\nPMID: 386304131. Neuroinformatics. 2024 Apr 17. doi: 10.1007/s12021-024-09663-9. Online ahead\\nof  print.\\n\\nGrowth-Associated Protein\\xa043 and Tensor-Based Morphometry Indices in Mild \\nCognitive Impairment.\\n\\nSeyedmirzaei H(1), Salmannezhad A(#)(2), Ashayeri H(#)(3), Shushtari A(#)(4), \\nFarazinia B(5), Heidari MM(6), Momayezi A(7), Shaki Baher S(8).\\n\\nAuthor information:\\n(1)Sports Medicine Research Center, Neuroscience Institute, Tehran University of \\nMedical Sciences, Tehran, Iran.\\n(2)Student Research Committee, Ghazvin University of Medical Sciences, Ghazvin, \\nIran.\\n(3)Student Research Committee, Tabriz University of Medical Sciences, Tabriz, \\nIran.\\n(4)Faculty of Medicine , Mazandaran University of Medical Sciences, Sari, Iran. \\nalishoushtari1377@gmail.com.\\n(5)Faculty of Economics and Management, Shiraz Branch, Islamic Azad University, \\nShiraz, Iran.\\n(6)Student Research Committee, Faculty of Medicine, Kashan University of Medical \\nSciences, Kashan, Iran.\\n(7)School of Chemical engineering, Iran University of Science and Technology, \\nTehran, Iran.\\n(8)Faculty of Medicine, Tehran Branch, Islamic Azad University, Tehran, Iran.\\n(#)Contributed equally\\n\\nGrowth-associated protein 43 (GAP-43) is found in the axonal terminal of neurons \\nin the limbic system, which is affected in people with Alzheimer\\'s disease (AD). \\nWe assumed GAP-43 may contribute to AD progression and serve as a biomarker. So, \\nin a two-year follow-up study, we assessed GAP-43 changes and whether they are \\ncorrelated with tensor-based morphometry (TBM) findings in patients with mild \\ncognitive impairment (MCI). We included MCI and cognitively normal (CN) people \\nwith available baseline and follow-up cerebrospinal fluid (CSF) GAP-43 and TBM \\nfindings from the ADNI database. We assessed the difference between the two \\ngroups and correlations in each group at each time point. CSF GAP-43 and TBM \\nmeasures were similar in the two study groups in all time points, except for the \\naccelerated anatomical region of interest (ROI) of CN subjects that were \\nsignificantly greater than those of MCI. The only significant correlations with \\nGAP-43 observed were those inverse correlations with accelerated and \\nnon-accelerated anatomical ROI in MCI subjects at baseline. Plus, all TBM \\nmetrics decreased significantly in all study groups during the follow-up in \\ncontrast to CSF GAP-43 levels. Our study revealed significant associations \\nbetween CSF GAP-43 levels and TBM indices among people of the AD spectrum.\\n\\n© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s12021-024-09663-9\\nPMID: 386304111. Immunol Res. 2024 Apr 17. doi: 10.1007/s12026-024-09480-x. Online ahead of \\nprint.\\n\\nβ-Indole-3-acetic acid attenuated collagen-induced arthritis through reducing \\nthe ubiquitination of Foxp3 via the AhR-TAZ-Tip60 pathway.\\n\\nSu X(1), Wang X(2), Zhang X(2), Sun Y(1), Jia Y(3)(4).\\n\\nAuthor information:\\n(1)Department of Chinese Medicine, Hebei University of Chinese Medicine, \\nShijiazhuang, 050200, China.\\n(2)Department of Integrative Chinese and Western Medicine, Hebei University of \\nChinese Medicine, Shijiazhuang, 050200, China.\\n(3)Department of Pharmacology, Hebei University of Chinese Medicine, \\nShijiazhuang, 050200, China. jiayugaihb@163.com.\\n(4)Hebei International Cooperation Center for Ion Channel Function and \\nInnovative Traditional Chinese Medicine, Shijiazhuang, 050091, China. \\njiayugaihb@163.com.\\n\\nMassive evidence shows that intestinal tryptophan metabolites affected by \\nintestinal flora can modulate the progression of rheumatoid arthritis (RA). \\nHowever, the effects and mechanisms of intestinal tryptophan metabolites on RA \\nare not yet detailed. Herein, we investigated the protective effects of \\nintestinal tryptophan metabolites on RA and its detailed mechanisms. In this \\nstudy, the collagen-induced arthritis (CIA) rat model was established. Based on \\nmetabolomics analysis, the contents of β-indole-3-acetic acid (IAA), \\nindolylpropionic acid, and indole-3-β-acrylic acid in the sera of CIA rats were \\nsignificantly less compared with those of the normal rats. Under the condition \\nof Treg or Th17 cell differentiation, IAA significantly promoted the \\ndifferentiation and activation of Treg cells instead of Th17 cells. Intestinal \\ntryptophan metabolites are well-known endogenic ligands of aryl hydrocarbon \\nreceptor (AhR). Not surprisingly, IAA increased the level of Foxp3 through \\nactivating the AhR pathway. Interestingly, IAA had little impact on the level of \\nFoxp3 mRNA, but reducing the ubiquitination and degradation of Foxp3. \\nMechanically, IAA reduced the expression of the transcriptional coactivator TAZ, \\nwhich was almost completely reversed by either AhR antagonist CH223191 or siRNA. \\nIn vitro, IAA decreased the combination of TAZ and the histone acetyltransferase \\nTip60, while it increased the combination of Tip60 and Foxp3. In CIA rats, oral \\nadministration of IAA increased the number of Treg cells and relieved the \\ninflammation. A combined use with CH223191 almost abolished the effect of IAA. \\nTaken together, IAA attenuated CIA by promoting the differentiation of Treg \\ncells through reducing the ubiquitination of Foxp3 via the AhR-TAZ-Tip60 \\npathway.\\n\\n© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s12026-024-09480-x\\nPMID: 386304081. Environ Sci Pollut Res Int. 2024 Apr 17. doi: 10.1007/s11356-024-33268-z.\\nOnline  ahead of print.\\n\\nAssociation between urinary BTEX metabolites and dyslexic odds among school-aged \\nchildren.\\n\\nLiu R(#)(1), Wan Y(#)(2), Zhu B(3), Liu Q(1), Wang H(1), Jiang Q(1), Feng Y(1), \\nZhu K(1), Zhao S(1), Xiang Z(1), Zhu Y(4), Song R(5).\\n\\nAuthor information:\\n(1)Department of Maternal and Child Health and MOE (Ministry of Education) Key \\nLab of Environment and Health, School of Public Health, Tongji Medical College, \\nHuazhong University of Science and Technology, No 13 Hangkong Road, Wuhan, \\n430030, Hubei, China.\\n(2)Center for Public Health Laboratory Service, Institute of Environmental \\nHealth, Wuhan Centers for Disease Control & Prevention, Wuhan, 430024, Hubei, \\nChina.\\n(3)Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, \\n310051, China.\\n(4)Department of Epidemiology and Biostatistics, School of Public Health, Wuhan \\nUniversity, Wuhan, 430072, China.\\n(5)Department of Maternal and Child Health and MOE (Ministry of Education) Key \\nLab of Environment and Health, School of Public Health, Tongji Medical College, \\nHuazhong University of Science and Technology, No 13 Hangkong Road, Wuhan, \\n430030, Hubei, China. songranran@hust.edu.cn.\\n(#)Contributed equally\\n\\nBenzene, toluene, ethylbenzene, and xylene (BTEX) are ubiquitous in the \\nenvironment, and all of them can cause neurotoxicity. However, the association \\nbetween BTEX exposure and dyslexia, a disorder with language network-related \\nregions in left hemisphere affected, remains unclear. We aimed to assess the \\nrelationship between BTEX exposure and dyslexic odds among school-aged children. \\nA case-control study, including 355 dyslexics and 390 controls from three cities \\nin China, was conducted. Six BTEX metabolites were measured in their\\xa0urine \\nsamples. Logistic regression model was used to explore the association between \\nthe\\xa0BTEX metabolites and the dyslexic odds. Urinary trans,trans-muconic acid \\n(MU: a metabolite of benzene) was significantly associated with an increased \\ndyslexic odds [odds ratio (OR)\\u2009=\\u20091.23, 95% confidence interval (CI): 1.01, \\n1.50], and the adjusted OR of the\\xa0dyslexic odds in the third tertile was 1.72 \\n(95% CI: 1.06, 2.77) compared to that in the lowest tertile regarding urinary MU \\nconcentration. Furthermore, the association between urinary MU level and \\nthe\\xa0dyslexic odds was more pronounced among children from low-income families \\nbased on stratified analyses. Urinary metabolite levels of toluene, \\nethylbenzene, and xylene were not found to be\\xa0associated with the dyslexic odds. \\nIn summary, elevated MU concentrations may be associated with an increased \\ndyslexic odds. We should take measures to reduce MU related exposure among \\nchildren, particularly those with low family income.\\n\\n© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \\npart of Springer Nature.\\n\\nDOI: 10.1007/s11356-024-33268-z\\nPMID: 386304001. Int J Clin Oncol. 2024 Apr 17. doi: 10.1007/s10147-024-02521-3. Online ahead\\nof  print.\\n\\nNew therapeutic target molecules for gastric and gastroesophageal junction \\ncancer.\\n\\nKawakami H(1).\\n\\nAuthor information:\\n(1)Department of Medical Oncology, Kindai University Faculty of Medicine, 377-2 \\nOhno-higashi, Osaka-sayama, 589-8511, Japan. kawakami_h@med.kindai.ac.jp.\\n\\nMolecularly targeted therapy for receptor tyrosine kinases (RTKs) has faced \\nlimitations in gastric and gastroesophageal junction (G/GEJ) cancer except for \\nHER2-targeted agents, possibly due to inappropriate assay selection that has \\nhindered identification of sensitive patients, in addition to coexisting genetic \\nabnormalities as well as intratumoral heterogeneity. Immunohistochemistry of \\nRTKs has, thus, proved largely unsuccessful for patient selection, and detection \\nof RTK gene amplification as a true oncogenic driver is problematic given the \\nsmall numbers of affected individuals. FGFR2 amplification is associated with \\npoor prognosis in G/GEJ cancer, and immunohistochemistry of the FGFR2b protein \\nisoform has proved effective for the detection of such FGFR2-dependent tumors. \\nPhase III and Ib/III trials of the FGFR2-targeted antibody bemarituzumab for \\nG/GEJ cancer overexpressing FGFR2b are ongoing based on the promising result in \\na phase II trial, especially in cases with an FGFR2b positivity of\\u2009≥\\u200910%. \\nChallenges to EGFR- and MET-targeted therapies are being tackled with \\nantibody-drug conjugates (ADCs) and bispecific antibodies. CLDN18.2 is expressed \\nin some G/GEJ tumors but lacks oncogenic driver potential, and the \\nCLDN18.2-targeted antibody zolbetuximab prolonged the survival of \\nCLDN18.2-positive G/GEJ cancer patients in phase III trials. Antibody-drug \\nconjugates and ADCs that target CLDN18.2 are also being pursued for treatment of \\nsuch patients. Similarly, targeting of nondriver molecules such as DKK1, TROP2, \\nand CEACAM5 is under investigation in early-stage clinical trials. This shift in \\nfocus from target molecules with driver potential to markers for precise drug \\ndelivery should increase the number of possible targets in G/GEJ cancer.\\n\\n© 2024. The Author(s) under exclusive licence to Japan Society of Clinical \\nOncology.\\n\\nDOI: 10.1007/s10147-024-02521-3\\nPMID: 386303831. Clin Oral Investig. 2024 Apr 17;28(5):253. doi: 10.1007/s00784-024-05631-4.\\n\\nLongevity of composite restorations in posterior teeth placed by dental \\nstudents: a 12-year retrospective study.\\n\\nAlonso ALL(1), Tirapelli C(2), Cruvinel PB(2), Cerqueira NM(1), Miranda CS(3), \\nCorona SAM(1), Souza-Gabriel AE(4).\\n\\nAuthor information:\\n(1)Department of Restorative Dentistry, School of Dentistry of Ribeirão Preto, \\nUniversity of São Paulo, Av. do Café s/n, Ribeirão Preto, São Paulo, 14040-904, \\nBrazil.\\n(2)Department of Dental Materials and Prosthodontics, School of Dentistry of \\nRibeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.\\n(3)Department of Accounting, School of Economics, Business and Accounting of \\nUniversity of São Paulo, Ribeirão Preto, Brazil.\\n(4)Department of Restorative Dentistry, School of Dentistry of Ribeirão Preto, \\nUniversity of São Paulo, Av. do Café s/n, Ribeirão Preto, São Paulo, 14040-904, \\nBrazil. aline.gabriel@forp.usp.br.\\n\\nOBJECTIVES: To evaluate the longevity of resin composite restorations placed in \\nposterior teeth by dental students, using data from electronic records from 2008 \\nto 2019.\\nMATERIALS AND METHODS: Demographic (gender and age) and clinical variables \\n(dental group, position in dental arch, and the number of restored surfaces) \\nwere evaluated. The 5-year follow-up was assessed according to the day the \\nrestoration was placed. Kaplan-Meier curves were generated to calculate the \\nannual failure rate. Data were analyzed by Chi-Square, Kruskal-Wallis, and \\nMann-Whitney tests (α\\u2009=\\u20090.05).\\nRESULTS: In total, 3.883 records relative to return periodicity were analyzed. \\nThe final sample consisted of 900 restorations from 479 patients. The majority \\nwere females, aged between 31 and 60. In total, 256 failures were reported \\n(success rate\\u2009=\\u200978%), showing an annual failure rate of 2.05%. The main reasons \\nfor failures were restoration replacement (55.5%), endodontics (21.9%), \\nprosthetics (14.5%) and extraction (8.2%). There was a higher risk of failure in \\nrestorations involving three or more surfaces (p\\u2009=\\u20090.000) and in patients over \\n60 years (p\\u2009<\\u20090.001). In females (p\\u2009=\\u20090.030), molars (p\\u2009=\\u20090.044), and maxillary \\nteeth (p\\u2009=\\u20090.038) failed in a shorter time.\\nCONCLUSIONS: Resin composite restorations placed in permanent posterior teeth by \\ndental students had high survival rates. The main reason for failure was the \\nreplacement of restorations. The age group and the number of restored surfaces \\nsignificantly affected the success of the restorations.\\nCLINICAL RELEVANCE: The electronic health records over 12 years showed that 78% \\nof the resin restorations in posterior teeth placed by dental students were \\nsuccessful for a minimum of five years.\\n\\n© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \\npart of Springer Nature.\\n\\nDOI: 10.1007/s00784-024-05631-4\\nPMID: 386303761. World J Microbiol Biotechnol. 2024 Apr 17;40(6):164. doi: \\n10.1007/s11274-024-03981-5.\\n\\nHow does active yeast supplementation reduce the deleterious effects of \\naflatoxins in Wistar rats? A radiolabeled assay and histopathological study.\\n\\nSica P(1), Domingues MA(2), Mota LA(2), Pinto AU(2), Baptista AAS(3), Horii \\nJ(2), Abdalla AL(4), Baptista AS(2).\\n\\nAuthor information:\\n(1)Department of Plant and Environmental Sciences, University of Copenhagen, 40 \\nThorvaldsenvej, Frederiksberg, 1870, Denmark. pietro@plen.ku.dk.\\n(2)Department of Agri-food Industry, Food and Nutrition, College of Agriculture \\n\"Luiz de Queiroz\", University of Sao Paulo\", Padua Dias Avenue, Piracicaba, Sao \\nPaulo, 13418-900, Brazil.\\n(3)Department of Preventive Veterinary Medicine, State University of Londrina, \\nLondrina, Parana, 86057-970, Brazil.\\n(4)Center for Nuclear Energy in Agriculture (CENA), University of Sao Paulo, \\n303, Centenario Avenue, Piracicaba, Sao Paulo, 13400-970, Brazil.\\n\\nThe aim of this study was to investigate the mechanisms by which yeasts \\n(Saccharomyces cerevisiae) control the toxic effects of aflatoxins, which are \\nnot yet fully understood. Radiolabeled aflatoxin B1 (AFB13H) was administered by \\ngavage to Wistar rats fed with aflatoxin (AflDiet) and aflatoxin supplemented \\nwith active dehydrated yeast Y904 (AflDiet\\u2009+\\u2009Yeast). The distribution of AFB13H \\nand its metabolites were analyzed at 24, 48 and 72\\xa0h by tracking back of the \\nradioactivity. No significant differences were observed between the AflDiet and \\nAflDiet\\u2009+\\u2009Yeast groups in terms of the distribution of labeled aflatoxin. At \\n72\\xa0h, for the AflDiet group the radiolabeled aflatoxin was distributed as \\nfollowing: feces (79.5%), carcass (10.5%), urine (1.7%), and intestine (7.4%); \\nin the AflDiet\\u2009+\\u2009Yeast the following distribution was observed: feces (76%), \\ncarcass (15%), urine (2.9%), and intestine (4.9%). These values were below 1% in \\nother organs. These findings indicate that even after 72\\xa0h considerable amounts \\nof aflatoxins remains in the intestines, which may play a significant role in \\nthe distribution and metabolism of aflatoxins and its metabolites over time. The \\npresence of yeast may not significantly affect this process. Furthermore, \\nhistopathological examination of hepatic tissues showed that the presence of \\nactive yeast reduced the severity of liver damage caused by aflatoxins, \\nindicating that yeasts control aflatoxin damage through biochemical mechanisms. \\nThese findings contribute to a better understanding of the mechanisms underlying \\nthe protective effects of yeasts against aflatoxin toxicity.\\n\\n© 2024. The Author(s).\\n\\nDOI: 10.1007/s11274-024-03981-5\\nPMID: 386303731. Pharmacoecon Open. 2024 Apr 17. doi: 10.1007/s41669-024-00489-4. Online ahead\\nof  print.\\n\\nCost of Care for Non-communicable Diseases: Which Types of Healthcare Providers \\nare the Most Economical in India\\'s Chhattisgarh State?\\n\\nGarg S(1), Tripathi N(2), Bebarta KK(2).\\n\\nAuthor information:\\n(1)State Health Resource Centre, Raipur, Chhattisgarh, India. koriya@gmail.com.\\n(2)State Health Resource Centre, Raipur, Chhattisgarh, India.\\n\\nBACKGROUND: Non-communicable diseases (NCDs) affect a large number of people \\nglobally and their burden has been growing. Healthcare for NCDs often involves \\nhigh out-of-pocket expenditure and rising costs of providing services. Financing \\nand providing care for NCDs have become a major challenge for health systems. \\nDespite the high burden of NCDs in India, there is little information available \\non the costs involved in NCD care.\\nMETHODS: The study was aimed at finding out the average monthly cost of \\noutpatient care per NCD patient. The average cost was defined as all resources \\nspent directly by government and citizens to get a month of care for a NCD \\npatient. The cost borne by the government on public facilities was taken into \\naccount and activity-based costing was used to apportion it to the function of \\nproviding outpatient NCD care. For robustness, time-driven activity-based \\ncosting and sensitivity analyses were also performed. The study was conducted in \\nChhattisgarh State and involved a household survey and a facility survey, \\nconducted simultaneously at the end of 2022. The surveys had a sample \\nrepresentative of the state, covering 3500 individuals above age of 30 years and \\n108 health facilities.\\nRESULTS: The average monthly cost per NCD patient was Indian Rupees (INR) 688 \\nfor public providers, INR 1389 for formal for-profit providers and INR 408 for \\ninformal private providers and they managed 53.5, 34.3 and 12.0% of NCD patients \\nrespectively. The disease profile of patients handled by different types of \\nproviders was similar. The average cost per patient was lowest for the primary \\ncare facilities in the public sector.\\nCONCLUSIONS: The average direct cost of NCD care for government and citizens put \\ntogether was substantially higher in case of formal for-profit providers \\ncompared with public facilities, even after taking into account the government \\nsubsidies to public sector. This has implications for allocative efficiency and \\nthe desired public-private provider mix in health systems.\\n\\n© 2024. The Author(s).\\n\\nDOI: 10.1007/s41669-024-00489-4\\nPMID: 386303631. Mol Cell Biochem. 2024 Apr 17. doi: 10.1007/s11010-024-05001-4. Online ahead\\nof  print.\\n\\nValproate decreases transgenerationally blood pressure by affecting \\nthyrotropin-releasing hormone promoter DNA methylation and gene expression in \\nspontaneously hypertensive rat.\\n\\nLanda MS(1)(2), Schuman ML(1)(2), Aisicovich M(1)(2), Peres Diaz LS(1)(2), \\nGironacci MM(3), García SI(4)(5)(6), Pirola CJ(7)(8).\\n\\nAuthor information:\\n(1)School of Medicine, Institute of Medical Research A. Lanari, Universidad de \\nBuenos Aires, Combatientes de Malvinas 3150, 1427, Ciudad Autonoma de Buenos \\nAires, Argentina.\\n(2)Department of Molecular Cardiology, Institute of Medical Research (IDIM), \\nNational Scientific and Technical Research Council (CONICET), Universidad de \\nBuenos Aires (UBA), Ciudad Autonoma de Buenos Aires, Argentina.\\n(3)Department of Biological Chemistry, Faculty of Pharmacy and Biochemistry, \\nSchool of Pharmacy and Biochemistry (IQUIFIB), National Scientific and Technical \\nResearch Council (CONICET), Universidad de Buenos Aires (UBA), Ciudad Autonoma \\nde Buenos Aires, Argentina.\\n(4)School of Medicine, Institute of Medical Research A. Lanari, Universidad de \\nBuenos Aires, Combatientes de Malvinas 3150, 1427, Ciudad Autonoma de Buenos \\nAires, Argentina. garcia.silvia@conicet.gov.ar.\\n(5)Department of Molecular Cardiology, Institute of Medical Research (IDIM), \\nNational Scientific and Technical Research Council (CONICET), Universidad de \\nBuenos Aires (UBA), Ciudad Autonoma de Buenos Aires, Argentina. \\ngarcia.silvia@conicet.gov.ar.\\n(6)Laboratory of Experimental Medicine, Hospital Alemán, Ciudad Autónoma de \\nBuenos Aires, Argentina. garcia.silvia@conicet.gov.ar.\\n(7)Department of Molecular Genetics and Biology of Complex Diseases, Center for \\nTraslational Research in Health, Maimonides University, Hidalgo 775, 1405, \\nCiudad Autonoma de Buenos Aires, Argentina. pirola.carlos@maimonides.edu.\\n(8)National Scientific and Technical Research Council (CONICET), Ciudad Autonoma \\nde Buenos Aires, Argentina. pirola.carlos@maimonides.edu.\\n\\nCentral TRH, a neuropeptide, is involved in cardiovascular regulation. We \\ndemonstrated that the overexpression of diencephalic TRH (dTRH) in SHR rats can \\nbe prevented by antisense treatment, normalizing blood pressure (BP). Valproate \\n(VPA) is an inhibitor of histone deacetylases (HDAC) which modulates gene \\nexpression through epigenetic modifications such as DNA methylation.\\nAIMS: Study the role of HDAC inhibition in the regulation of dTRH gene \\nexpression and its effect on the pathogenesis of hypertension.\\nMAIN METHODS: We treated 7-weeks-old male and female SHR and WKY rats with VPA \\nfor 10\\xa0weeks and evaluated BP, dTRH mRNA and methylation gene status.\\nKEY FINDINGS: VPA attenuated the elevated BP and dTRH mRNA expression \\ncharacteristic of SHR. Indeed, we found a significant 62% reduction in dTRH mRNA \\nexpression in the SHR\\u2009+\\u2009VPA group compared to control SHR. The decrease TRH mRNA \\nexpression induced by VPA was confirmed \"in vitro\" in a primary neuron culture \\nusing trichostatin A. With methylation specific PCR we demonstrated a \\nsignificant increase in TRH promoter DNA methylation level in SHR\\u2009+\\u2009VPA group \\ncompared to control SHR. After 2\\xa0weeks of treatment interruption, rats were \\nmated. Although they did not receive any treatment, the offspring born from \\nVPA-treated SHR parents showed similar changes in BP, dTRH expression and \\nmethylation status, implying a transgenerational inheritance. Our findings \\nsuggest that dTRH modulation by epigenetics mechanism affects BP and could be \\ninherited by the next generation in SHR rats.\\n\\n© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s11010-024-05001-4\\nPMID: 38630362'}\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "The chain below takes in the question and then creates a list of keywords which are used to create a context which the actual question would be answered upon.\n",
    "\"\"\"\n",
    "key_search = KEY_PROMPT | ChatOpenAI(model='gpt-4-1106-preview', temperature=1) | {\n",
    "    'question': StrOutputParser()} | RunnablePassthrough.assign(\n",
    "    text=lambda x: get_entrez(parse_keywords(x)))\n",
    "\n",
    "output1=key_search.invoke(\n",
    "        {\n",
    "            \"question\":question\n",
    "        }\n",
    "    )\n",
    "# print(output1)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:52:26.655059400Z",
     "start_time": "2024-04-17T18:51:09.952729500Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Document(page_content='1. Chem Commun (Camb). 2024 Apr 17. doi: 10.1039/d4cc01111b. Online ahead of\\nprint.\\n\\nHalloysite-derived mesoporous silica with high ionic conductivity improves Li-S \\nbattery performance.\\n\\nAo R(1), Zhu Z(1), Zhang S(1)(2), Zhang Q(2)(3), Yan C(1), Tu F(4), Li T(4), Li \\nMG(5), Fu L(1)(2)(3), Tang A(1)(3), Yang H(1)(2)(3).'), Document(page_content='Author information:\\n(1)Engineering Research Center of Nano-Geomaterials of Ministry of Education, \\nLaboratory of Advanced Mineral Materials, Faculty of Materials Science and \\nChemistry, China University of Geosciences, Wuhan 430074, China. \\ntangaidong@cug.edu.cn.\\n(2)College of Chemistry and Chemical Engineering, Central South University, \\nChangsha 410083, China. adtang@csu.edu.cn.\\n(3)Hunan Key Laboratory of Mineral Materials and Application, School of Minerals \\nProcessing and Bioengineering, Central South University, Changsha 410083, China. \\nhmyang@csu.edu.cn.\\n(4)Changsha Research Institute of Mining and Metallurgy Co. LTD., Changsha \\n410012, P. R. China.\\n(5)Division of Integrative Systems and Design, Department of Electronic and \\nComputer Engineering, The Hong Kong University of Science and Technology, Clear \\nWater Bay, Kowloon, Hong Kong SAR, P. R. China.'), Document(page_content='The slow Li+ transport rate in the thick sulfur cathode of the Li-S battery \\naffects its capacity and cycling performance. Herein, Fe-doped highly ordered \\nmesoporous silica material (Fe-HSBA-15) as a sulfur carrier of the Li-S battery \\nshows high ion conductivity (1.10 mS cm-1) and Li+ transference number (0.77). \\nThe Fe-HSBA-15/S cell has an initial capacity of up to 1216.7 mA h g-1 at 0.2C \\nand good stability. Impressively, at a high sulfur load of 4.34 mg cm-2, the \\nFe-HSBA-15/S cell still maintains an area specific capacity of 4.47 mA h cm-2 \\nafter 100 cycles. This is because Fe-HSBA-15 improves the Li+ diffusion behavior \\nthrough the ordered mesoporous structure. Theoretical calculations also \\nconfirmed that the doping of iron enhances the adsorption of polysulfides, \\nreduces the band gap and makes the catalytic activity stronger.\\n\\nDOI: 10.1039/d4cc01111b\\nPMID: 386305321. JMIR Med Educ. 2024 Apr 17;10:e50118. doi: 10.2196/50118.'), Document(page_content='DOI: 10.1039/d4cc01111b\\nPMID: 386305321. JMIR Med Educ. 2024 Apr 17;10:e50118. doi: 10.2196/50118.\\n\\nDevelopment of Web-Based Education Modules to Improve Carer Engagement in Cancer \\nCare: Design and User Experience Evaluation of the e-Triadic Oncology (eTRIO) \\nModules for Clinicians, Patients, and Carers.\\n\\nLaidsaar-Powell R(1)(2), Giunta S(1), Butow P(1)(2), Keast R(1), Koczwara \\nB(3)(4), Kay J(5), Jefford M(6), Turner S(7)(8), Saunders C(9), Schofield \\nP(6)(10)(11), Boyle F(8)(12), Yates P(13), White K(14), Miller A(15), Butt Z(1), \\nBonnaudet M(5)(16), Juraskova I(1)(2).'), Document(page_content='Author information:\\n(1)Centre for Medical Psychology & Evidence-based Decision-making, School of \\nPsychology, The University of Sydney, Sydney, Australia.\\n(2)Psycho-Oncology Co-operative Research Group, The University of Sydney, \\nSydney, Australia.\\n(3)Flinders Medical Centre, Adelaide, Australia.\\n(4)College of Medicine and Public Health, Flinders University, Adelaide, \\nAustralia.\\n(5)School of Computer Science, The University of Sydney, Sydney, Australia.\\n(6)Health Services Research and Implementation Science, Peter MacCallum Cancer \\nCentre, Melbourne, Australia.\\n(7)Department of Radiation Oncology, Westmead Hospital, Westmead, Australia.\\n(8)Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.\\n(9)Department of Surgery, Royal Melbourne Hospital, University of Melbourne, \\nMelbourne, Australia.\\n(10)Department of Psychology and Iverson Health Innovation Research Institute, \\nSwinburne University, Melbourne, Australia.\\n(11)Sir Peter MacCallum Department of Oncology, The University of Melbourne, \\nMelbourne, Australia.\\n(12)Patricia Ritchie Centre for Cancer Care & Research, Mater Hospital, Sydney, \\nAustralia.'), Document(page_content='Melbourne, Australia.\\n(12)Patricia Ritchie Centre for Cancer Care & Research, Mater Hospital, Sydney, \\nAustralia.\\n(13)Faculty of Health, Queensland University of Technology, Brisbane, Australia.\\n(14)Susan Wakil School of Nursing, The Daffodil Centre, The University of \\nSydney, a joint venture with Cancer Council New South Wales, Sydney, Australia.\\n(15)Cancer Council New South Wales, Sydney, Australia.\\n(16)School of Electrical Engineering and Computer Science, Kungliga Tekniska \\nhögskolan Royal Institute of Technology, Stockholm, Sweden.'), Document(page_content='BACKGROUND: Carers often assume key roles in cancer care. However, many carers \\nreport feeling disempowered and ill-equipped to support patients. Our group \\npublished evidence-based guidelines (the Triadic Oncology [TRIO] Guidelines) to \\nimprove oncology clinician engagement with carers and the management of \\nchallenging situations involving carers.\\nOBJECTIVE: To facilitate implementation of the TRIO Guidelines in clinical \\npractice, we aimed to develop, iteratively refine, and conduct user testing of a \\nsuite of evidence-based and interactive web-based education modules for oncology \\nclinicians (e-Triadic Oncology [eTRIO]), patients with cancer, and carers (eTRIO \\nfor Patients and Carers [eTRIO-pc]). These were designed to improve carer \\ninvolvement, communication, and shared decision-making in the cancer management \\nsetting.\\nMETHODS: The eTRIO education modules were based on extensive research, including \\nsystematic reviews, qualitative interviews, and consultation analyses. Guided by \\nthe person-based approach, module content and design were reviewed by an expert \\nadvisory group comprising academic and clinical experts (n=13) and consumers \\n(n=5); content and design were continuously and iteratively refined. User'), Document(page_content='advisory group comprising academic and clinical experts (n=13) and consumers \\n(n=5); content and design were continuously and iteratively refined. User \\nexperience testing (including \"think-aloud\" interviews and administration of the \\nSystem Usability Scale [SUS]) of the modules was completed by additional \\nclinicians (n=5), patients (n=3), and carers (n=3).\\nRESULTS: The final clinician module comprises 14 sections, requires \\napproximately 1.5 to 2 hours to complete, and covers topics such as \\ncarer-inclusive communication and practices; supporting carer needs; and \\nmanaging carer dominance, anger, and conflicting patient-carer wishes. The \\nusability of the module was rated by 5 clinicians, with a mean SUS score of 75 \\n(SD 5.3), which is interpreted as good. Clinicians often desired information in \\na concise format, divided into small \"snackable\" sections that could be easily \\nrecommenced if they were interrupted. The carer module features 11 sections; \\nrequires approximately 1.5 hours to complete; and includes topics such as the \\nimportance of carers, carer roles during consultations, and advocating for the \\npatient. The patient module is an adaptation of the relevant carer module'), Document(page_content='importance of carers, carer roles during consultations, and advocating for the \\npatient. The patient module is an adaptation of the relevant carer module \\nsections, comprising 7 sections and requiring 1 hour to complete. The average \\nSUS score as rated by 6 patients and carers was 78 (SD 16.2), which is \\ninterpreted as good. Interactive activities, clinical vignette videos, and \\nreflective learning exercises are incorporated into all modules. Patient and \\ncarer consumer advisers advocated for empathetic content and tone throughout \\ntheir modules, with an easy-to-read and navigable module interface.\\nCONCLUSIONS: The eTRIO suite of modules were rigorously developed using a \\nperson-based design methodology to meet the unique information needs and \\nlearning requirements of clinicians, patients, and carers, with the goal of \\nimproving effective and supportive carer involvement in cancer consultations and \\ncancer care.'), Document(page_content=\"©Rebekah Laidsaar-Powell, Sarah Giunta, Phyllis Butow, Rachael Keast, Bogda \\nKoczwara, Judy Kay, Michael Jefford, Sandra Turner, Christobel Saunders, \\nPenelope Schofield, Frances Boyle, Patsy Yates, Kate White, Annie Miller, Zoe \\nButt, Melanie Bonnaudet, Ilona Juraskova. Originally published in JMIR Medical \\nEducation (https://mededu.jmir.org), 17.04.2024.\\n\\nDOI: 10.2196/50118\\nPMID: 386305311. JMIR Hum Factors. 2024 Apr 17;11:e54172. doi: 10.2196/54172.\\n\\nA Smartphone App to Support Self-Management for People Living With Sjögren's \\nSyndrome: Qualitative Co-Design Workshops.\\n\\nMcCallum C(#)(1), Campbell M(#)(2), Vines J(3), Rapley T(4), Ellis J(5), Deary \\nV(5), Hackett K(4).\"), Document(page_content='McCallum C(#)(1), Campbell M(#)(2), Vines J(3), Rapley T(4), Ellis J(5), Deary \\nV(5), Hackett K(4).\\n\\nAuthor information:\\n(1)Faculty of Engineering, University of Bristol, Bristol, United Kingdom.\\n(2)Institute for Collective Place Leadership, Teesside University, \\nMiddlesbrough, United Kingdom.\\n(3)School of Informatics, University of Edinburgh, Edinburgh, United Kingdom.\\n(4)Department of Social Work, Education and Community Wellbeing, Northumbria \\nUniversity, Newcastle upon Tyne, United Kingdom.\\n(5)Department of Psychology, Northumbria University, Newcastle upon Tyne, United \\nKingdom.\\n(#)Contributed equally'), Document(page_content=\"BACKGROUND: Sjögren's syndrome (SS) is the second most common autoimmune \\nrheumatic disease, and the range of symptoms includes fatigue, dryness, sleep \\ndisturbances, and pain. Smartphone apps may help deliver a variety of cognitive \\nand behavioral techniques to support self-management in SS. However, app-based \\ninterventions must be carefully designed to promote engagement and motivate \\nbehavior change.\\nOBJECTIVE: We aimed to explore self-management approaches and challenges \\nexperienced by people living with SS and produce a corresponding set of design \\nrecommendations that inform the design of an engaging, motivating, and \\nevidence-based self-management app for those living with SS.\\nMETHODS: We conducted a series of 8 co-design workshops and an additional 3 \\ninterviews with participants who were unable to attend a workshop. These were \\naudio recorded, transcribed, and initially thematically analyzed using an \\ninductive approach. Then, the themes were mapped to the Self-Determination \\nTheory domains of competency, autonomy, and relatedness.\\nRESULTS: Participants experienced a considerable demand in the daily work \\nrequired in self-managing their SS. The condition demanded unrelenting, \\nfluctuating, and unpredictable mental, physical, and social efforts.\"), Document(page_content=\"RESULTS: Participants experienced a considerable demand in the daily work \\nrequired in self-managing their SS. The condition demanded unrelenting, \\nfluctuating, and unpredictable mental, physical, and social efforts. \\nParticipants used a wide variety of techniques to self-manage their symptoms; \\nhowever, their sense of competency was undermined by the complexity and \\ninterconnected nature of their symptoms and affected by interactions with \\nothers. The daily contexts in which this labor was occurring revealed ample \\nopportunities to use digital health aids. The lived experience of participants \\nshowed that the constructs of competency, autonomy, and relatedness existed in a \\ncomplex equilibrium with each other. Sometimes, they were disrupted by tensions, \\nwhereas on other occasions, they worked together harmoniously.\\nCONCLUSIONS: An SS self-management app needs to recognize the complexity and \\noverlap of symptoms and the complexities of managing the condition in daily \\nlife. Identifying techniques that target several symptoms simultaneously may \\nprevent users from becoming overwhelmed. Including techniques that support \\nassertiveness and communication with others about the condition, its symptoms, \\nand users' limitations may support users in their interactions with others and \\nimprove engagement in symptom management strategies.\\xa0For digital health aids \\n(such as self-management apps) to provide meaningful support, they should be\"), Document(page_content=\"and users' limitations may support users in their interactions with others and \\nimprove engagement in symptom management strategies.\\xa0For digital health aids \\n(such as self-management apps) to provide meaningful support, they should be \\ndesigned according to human needs such as competence, autonomy, and relatedness. \\nHowever, the complexities among the 3 Self-Determination Theory constructs \\nshould be carefully considered, as they present both design difficulties and \\nopportunities.\"), Document(page_content='©Claire McCallum, Miglena Campbell, John Vines, Tim Rapley, Jason Ellis, Vincent \\nDeary, Katie Hackett. Originally published in JMIR Human Factors \\n(https://humanfactors.jmir.org), 17.04.2024.\\n\\nDOI: 10.2196/54172\\nPMID: 386305301. JMIR Public Health Surveill. 2024 Apr 17;10:e50996. doi: 10.2196/50996.\\n\\nAssociation Between Frequency of Muscle-Strengthening Exercise and Depression \\nSymptoms Among Middle and High School Students: Cross-Sectional Survey Study.\\n\\nWang H(1), Du H(2)(3), Guan Y(1), Zhong J(1), Li N(1), Pan J(1), Yu M(1).\\n\\nAuthor information:\\n(1)Department of Noncommunicable Disease Control and Prevention, Zhejiang \\nProvincial Center for Disease Control and Prevention, Hangzhou, China.\\n(2)Medical Research Council Population Health Research Unit, Nuffield Department \\nof Population Health, University of Oxford, Oxford, United Kingdom.\\n(3)Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield \\nDepartment of Population Health, University of Oxford, Oxford, United Kingdom.'), Document(page_content='BACKGROUND: Existing literature on the association between the frequency of \\nmuscle-strengthening exercise (MSE) and depression among adolescents is limited \\nand contradictory.\\nOBJECTIVE: This study aimed to elucidate the association of MSE frequency with \\ndepression symptoms among middle and high school students in China.\\nMETHODS: A total of 27,070 students in grades 7-12 from 376 middle and high \\nschools were surveyed using an anonymous self-administered questionnaire between \\nApril and June 2022. Information on engaging in MSE was self-reported, and \\ndepression symptoms were assessed using the Patient Health Questionnaire-9 \\n(PHQ-9). Poisson regression was used to examine the association between MSE \\nfrequency and depression symptoms.\\nRESULTS: Among the 27,006 eligible students, 51.6% (n=13,933) were boys, and the \\nmean age was 15.6 (SD 1.7) years. The overall prevalence of meeting MSE \\nrecommendations (ie, engaging in MSE ≥3 days/week) was 34.6% (95% CI \\n32.6%-36.6%; n=9145); the prevalence was higher in boys (43.8%, 95% CI'), Document(page_content='32.6%-36.6%; n=9145); the prevalence was higher in boys (43.8%, 95% CI \\n41.8%-45.8%; 6067/13,933) than in girls (24.3%, 95% CI 22%-26.6%; 3078/13,073; \\nP<.001). A total of 5882 (21.8%) students reported having depression symptoms. \\nAfter adjustment for sociodemographic status, lifestyle factors, academic \\nperformance, and experience of physical fighting, compared to students who did \\nnot engage in MSE, the prevalence ratios (PRs) for depression symptoms were 0.98 \\n(95% CI 0.97-0.99) for those engaging in MSE once a week, 0.95 (95% CI \\n0.93-0.97) for 2 days/week, 0.93 (95% CI 0.90-0.96) for 3 days/week, 0.90 (95% \\nCI 0.87-0.94) for 4 days/week, 0.88 (95% CI 0.84-0.93) for 5 days/week, 0.86'), Document(page_content='CI 0.87-0.94) for 4 days/week, 0.88 (95% CI 0.84-0.93) for 5 days/week, 0.86 \\n(95% CI 0.81-0.92) for 6 days/week, and 0.84 (95% CI 0.78-0.90) for 7 days/week, \\nrespectively.\\nCONCLUSIONS: The overall prevalence of meeting MSE recommendations among Chinese \\nadolescents is low. The frequency of MSE was inversely associated with \\ndepression symptoms.'), Document(page_content=\"©Hao Wang, Huaidong Du, Yunqi Guan, Jieming Zhong, Na Li, Jin Pan, Min Yu. \\nOriginally published in JMIR Public Health and Surveillance \\n(https://publichealth.jmir.org), 17.04.2024.\\n\\nDOI: 10.2196/50996\\nPMID: 386305291. JMIR Res Protoc. 2024 Apr 17;13:e54406. doi: 10.2196/54406.\\n\\nPsychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: \\nProtocol for a Pilot Randomized Controlled Trial.\\n\\nGoel A(#)(1)(2), Kapoor B(#)(1)(3), Chan H(4), Ladha K(1)(2)(5), Katz \\nJ(2)(6)(7)(8)(9), Clarke H(2)(7)(8), Pazmino-Canizares J(1), Thomas Z(1), Philip \\nK(1)(4), Mattina G(1), Ritvo P(6)(9).\"), Document(page_content=\"Author information:\\n(1)Department of Anesthesia and Pain Medicine, St Michael's Hospital, Toronto, \\nON, Canada.\\n(2)Department of Anesthesiology and Pain Medicine, University of Toronto, \\nToronto, ON, Canada.\\n(3)Department of Medicine, Royal College of Surgeons in Ireland, Dublin, \\nIreland.\\n(4)Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.\\n(5)Institute of Health Policy, Management and Evaluation, University of Toronto, \\nToronto, ON, Canada.\\n(6)Department of Psychology, York University, Toronto, ON, Canada.\\n(7)Department of Anesthesia and Pain Management, Toronto General Hospital, \\nToronto, ON, Canada.\\n(8)Centre for the Study of Pain, University of Toronto, Toronto, ON, Canada.\\n(9)School of Kinesiology and Health Sciences, York University, Toronto, ON, \\nCanada.\\n(#)Contributed equally\"), Document(page_content=\"BACKGROUND: Chronic pain affects approximately 8 million Canadians (~20%), \\nimpacting their physical and mental health while burdening the health care \\nsystem with costs of upwards of US $60 billion a year. Indeed, patients are \\noften trialed on numerous medications over several years without reductions to \\ntheir symptoms. Therefore, there is an urgent need to identify new therapies for \\nchronic pain to improve patients' quality of life, increase the availability of \\ntreatment options, and reduce the burden on the health care system.\\nOBJECTIVE: The primary objective of this study is to examine the feasibility of \\na parallel 3-arm pilot randomized controlled trial whereby patients are \\nrandomized to either intravenous ketamine alone, cognitive behavioral therapy \\n(CBT) and mindfulness meditation (MM) training (CBT/MM), or the combination of \\nintravenous ketamine and CBT/MM. The secondary outcome is to assess the \\ndurability and efficacy of combination intravenous ketamine and CBT/MM for \\ntreatment of chronic pain as compared to CBT/MM or intravenous ketamine alone \\n(assessed at week 20 of the study).\\nMETHODS: This is a single-center, 16-week, 3-arm pilot study that will take \\nplace at the Chronic Pain Clinic at St. Michael's Hospital, Toronto, Ontario,\"), Document(page_content=\"METHODS: This is a single-center, 16-week, 3-arm pilot study that will take \\nplace at the Chronic Pain Clinic at St. Michael's Hospital, Toronto, Ontario, \\nwhich receives 1000 referrals per year. Patients will be enrolled in the study \\nfor a total of 20 weeks. Participants who are allocated CBT/MM therapy will \\nreceive remote weekly psychotherapy from week 1 to week 16, inclusive of health \\ncoaching administered through the NexJ Health Inc (NexJ Health) platform. \\nPatients who are allocated ketamine-infusion therapy will receive monthly \\nketamine infusion treatments on weeks 2, 7, and 12. Patients who are allocated \\nketamine+CBT/MM will receive weekly psychotherapy from weeks 1 to 16, inclusive, \\nas well as ketamine infusion treatments on weeks 2, 7, and 12. We will be \\nassessing recruitment rates, consent rates, withdrawal rates, adherence, missing \\ndata, and adverse events as pilot outcome measures. Secondary clinical outcomes \\ninclude changes relative to baseline in pain intensity and pain interference.\\nRESULTS: As of November 1, 2023, the recruitment process has not been initiated. \\nGiven the recruitment, consent, and intervention target of 30 participants for \\nthis feasibility study, with each patient undergoing monitoring and treatments\"), Document(page_content='RESULTS: As of November 1, 2023, the recruitment process has not been initiated. \\nGiven the recruitment, consent, and intervention target of 30 participants for \\nthis feasibility study, with each patient undergoing monitoring and treatments \\nfor a course of 20 weeks, we expect to complete the study by December 2025.\\nCONCLUSIONS: This study assesses the feasibility of conducting a 3-arm \\nrandomized controlled trial to examine the effects of ketamine administration \\nwith the concurrent use of CBT/MM in a population with chronic neuropathic pain. \\nThe results of this pilot randomized controlled trial will inform the \\ndevelopment of a larger-scale randomized controlled trial. Future studies will \\nbe aimed at including a sufficiently powered sample that will inform decisions \\nabout optimal treatment calibration and treatment effect duration.\\nTRIAL REGISTRATION: ClinicalTrials.gov NCT05639322; \\nhttps://classic.clinicaltrials.gov/ct2/show/NCT05639322.\\nINTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/54406.'), Document(page_content='©Akash Goel, Bhavya Kapoor, Hillary Chan, Karim Ladha, Joel Katz, Hance Clarke, \\nJanneth Pazmino-Canizares, Zaaria Thomas, Kaylyssa Philip, Gabriella Mattina, \\nPaul Ritvo. Originally published in JMIR Research Protocols \\n(https://www.researchprotocols.org), 17.04.2024.\\n\\nDOI: 10.2196/54406\\nPMID: 386305241. Mol Biol Cell. 2024 Apr 17:mbcE24020093. doi: 10.1091/mbc.E24-02-0093. Online \\nahead of print.\\n\\nA Methodology for Specific Disruption of Microtubule Polymerization into \\nDendritic Spines.\\n\\nHolland ED(1), Miller HL(1), Millette MM(2), Taylor RJ(2), Drucker GL(2), Dent \\nEW(2).\\n\\nAuthor information:\\n(1)Neuroscience Training Program, University of Wisconsin-Madison, WI 53705.\\n(2)Department of Neuroscience, School of Medicine and Public Health, Madison, WI \\n53705.'), Document(page_content='Dendritic spines, the mushroom-shaped extensions along dendritic shafts of \\nexcitatory neurons, are critical for synaptic function and are one of the first \\nneuronal structures disrupted in neurodevelopmental and neurodegenerative \\ndiseases. Microtubule (MT) polymerization into dendritic spines is an \\nactivity-dependent process capable of affecting spine shape and function. \\nStudies have shown that MT polymerization into spines occurs specifically in \\nspines undergoing plastic changes. However, discerning the function of MT \\ninvasion of dendritic spines requires the specific inhibition of MT \\npolymerization into spines, while leaving MT dynamics in the dendritic shaft, \\nsynaptically connected axons and associated glial cells intact. This is not \\npossible with the unrestricted, bath application of pharmacological compounds. \\nTo specifically disrupt MT entry into spines we coupled a MT elimination domain \\n(MTED) from the Efa6 protein to the actin filament-binding peptide LifeAct. \\nLifeAct was chosen because actin filaments are highly concentrated in spines and \\nare necessary for MT invasions. Temporally controlled expression of this \\nLifeAct-MTED construct inhibits MT entry into dendritic spines, while preserving'), Document(page_content='are necessary for MT invasions. Temporally controlled expression of this \\nLifeAct-MTED construct inhibits MT entry into dendritic spines, while preserving \\ntypical MT dynamics in the dendrite shaft. Expression of this construct will \\nallow for the determination of the function of MT invasion of spines and more \\nbroadly, to discern how MT-actin interactions affect cellular processes.'), Document(page_content='DOI: 10.1091/mbc.E24-02-0093\\nPMID: 386305191. Analyst. 2024 Apr 17. doi: 10.1039/d4an00181h. Online ahead of print.\\n\\nThermal evaporation as sample preparation for silver-assisted laser \\ndesorption/ionization mass spectrometry imaging of cholesterol in amyloid \\ntissues.\\n\\nStrnad Š(1), Vrkoslav V(1), Mengr A(1), Fabián O(2)(3), Rybáček J(1), Kubánek \\nM(2), Melenovský V(2), Maletínská L(1), Cvačka J(1).\\n\\nAuthor information:\\n(1)Institute of Organic Chemistry and Biochemistry of the Czech Academy of \\nSciences, 166 10, Prague, Czech Republic. vladimir.vrkoslav@uochb.cas.cz.\\n(2)Institute for Clinical and Experimental Medicine, 140 21, Prague, Czech \\nRepublic.\\n(3)Department of Pathology and Molecular Medicine, Third Faculty of Medicine, \\nCharles University and Thomayer Hospital, 140 59, Prague, Czech Republic.'), Document(page_content=\"Cholesterol plays an important biological role in the body, and its disruption \\nin homeostasis and synthesis has been implicated in several diseases. Mapping \\nthe locations of cholesterol is crucial for gaining a better understanding of \\nthese conditions. Silver deposition has proven to be an effective method for \\nanalyzing cholesterol using mass spectrometry imaging (MSI). We optimized and \\nevaluated thermal evaporation as an alternative deposition technique to \\nsputtering for silver deposition in MSI of cholesterol. A silver layer with a \\nthickness of 6 nm provided an optimal combination of cholesterol signal \\nintensity and mass resolution. The deposition of an ultrathin nanofilm of silver \\nenabled high-resolution MSI with a pixel size of 10 μm. We used this optimized \\nmethod to visualize the distribution of cholesterol in the senile plaques in the \\nbrains of APP/PS1 mice, a model that resembles Alzheimer's disease pathology. We \\nfound that cholesterol was evenly distributed across the frontal cortex tissue, \\nwith no evidence of plaque-like accumulation. Additionally, we investigated the \\npresence and distribution of cholesterol in myocardial sections of a human heart \\naffected by wild-type ATTR amyloidosis. We identified the presence of \\ncholesterol in areas with amyloid deposition, but complete colocalization was \\nnot observed.\"), Document(page_content='DOI: 10.1039/d4an00181h\\nPMID: 386305031. JAMA Netw Open. 2024 Apr 1;7(4):e246858. doi:\\n10.1001/jamanetworkopen.2024.6858.\\n\\nClinician Burnout and Effectiveness of Guideline-Recommended Psychotherapies.\\n\\nSayer NA(1)(2)(3), Kaplan A(1)(2), Nelson DB(1)(2), Wiltsey Stirman S(4)(5), \\nRosen CS(4)(5).\\n\\nAuthor information:\\n(1)Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care \\nSystem, Minneapolis, Minnesota.\\n(2)Department of Medicine, University of Minnesota, Minneapolis.\\n(3)Department of Psychiatry and Behavioral Sciences, University of Minnesota, \\nMinneapolis.\\n(4)National Center for Posttraumatic Stress Disorder, Dissemination and Training \\nDivision at the Veterans Affairs Palo Alto Health Care System, Palo Alto, \\nCalifornia.\\n(5)Department of Psychiatry and Behavioral Sciences, Stanford University School \\nof Medicine, Stanford, California.'), Document(page_content=\"IMPORTANCE: Clinician burnout has been associated with clinician outcomes, but \\nthe association with patient outcomes remains unclear.\\nOBJECTIVE: To evaluate the association between clinician burnout and the \\noutcomes of patients receiving of guideline-recommended trauma-focused \\npsychotherapies for posttraumatic stress disorder (PTSD).\\nDESIGN, SETTING, AND PARTICIPANTS: This cohort study was set at the US Veterans \\nAffairs Health Care System and included licensed therapists who provided \\ntrauma-focused psychotherapies and responded to an online survey between May 2 \\nand October 8, 2019, and their patients who initiated a trauma-focused therapy \\nduring the following year. Patient data were collected through December 31, \\n2020. Data were analyzed from May to September 2023.\\nEXPOSURES: Therapists completing the survey reported burnout with a 5-point \\nvalidated measure taken from the Physician Worklife Study. Burnout was defined \\nas scores of 3 or more.\\nMAIN OUTCOMES AND MEASURES: The primary outcome was patients' clinically \\nmeaningful improvement in PTSD symptoms according to the PTSD Checklist for the \\nDiagnostic and Statistical Manual of Mental Disorders (Fifth Edition). Patient \\ndropout, therapist adherence, and session spacing was assessed through\"), Document(page_content='meaningful improvement in PTSD symptoms according to the PTSD Checklist for the \\nDiagnostic and Statistical Manual of Mental Disorders (Fifth Edition). Patient \\ndropout, therapist adherence, and session spacing was assessed through \\nelectronic health records. Multivariable random-effects logistic regression \\nexamined the association of therapist burnout and clinically meaningful \\nimprovement, adjusted for case-mix.\\nRESULTS: In this study, 165 of 180 (91.7%) therapists (89 [53.9%] female) \\ncompleted the burnout measure and provided trauma-focused psychotherapies to \\n1268 patients (961 [75.8%] male) with outcome data. Fifty-eight (35.2%) \\ntherapists endorsed burnout. One third of patients (431 [34.0%]) met criterion \\nfor clinically meaningful improvement. Clinically meaningful improvement in PTSD \\nsymptoms was experienced by 120 (28.3%) of the 424 patients seen by therapists \\nwho reported burnout and 311 (36.8%) of the 844 patients seen by therapists \\nwithout burnout. Burnout was associated with lower odds of clinically meaningful \\nimprovement (adjusted odds ratio [OR],0.63; 95% CI, 0.48-0.85). The odds of \\nclinically meaningful improvement were reduced for patients who dropped out (OR,'), Document(page_content='improvement (adjusted odds ratio [OR],0.63; 95% CI, 0.48-0.85). The odds of \\nclinically meaningful improvement were reduced for patients who dropped out (OR, \\n0.15; 95% CI, 0.11-0.20) and had greater session spacing (OR, 0.80; 95% CI, \\n0.70-0.92). Therapist adherence was not associated with therapy effectiveness. \\nAdjusting for dropout or session spacing did not meaningfully alter the \\nmagnitude of the association between burnout and clinically meaningful \\nimprovement.\\nCONCLUSIONS AND RELEVANCE: In this prospective cohort study, therapist burnout \\nwas associated with reduced effectiveness of trauma-focused psychotherapies. \\nStudying when and how burnout affects patient outcomes may inform workplace \\ninterventions.'), Document(page_content='DOI: 10.1001/jamanetworkopen.2024.6858\\nPMID: 386304771. JAMA Surg. 2024 Apr 17. doi: 10.1001/jamasurg.2024.0718. Online ahead of\\nprint.\\n\\nPlacebo Control and Blinding in Randomized Trials of Procedural Interventions: A \\nSystematic Review and Meta-Regression.\\n\\nRajkumar CA(1), Thomas KE(2), Foley M(1), Ganesananthan S(1), Evans H(1), \\nSimader F(1), Syam S(1), Nour D(3), Beattie C(4), Khan C(1), Reddy RK(1), \\nAhmed-Jushuf F(1), Francis DP(1), Shun-Shin M(1), Al-Lamee RK(1).\\n\\nAuthor information:\\n(1)National Heart and Lung Institute, Imperial College London, London, United \\nKingdom.\\n(2)Division of Cardiovascular Medicine, University of Oxford, Oxford, United \\nKingdom.\\n(3)Royal North Shore Hospital, Sydney, New South Wales, Australia.\\n(4)Royal Free London National Health Service Foundation Trust, London, United \\nKingdom.'), Document(page_content='IMPORTANCE: Unlike medications, procedural interventions are rarely trialed \\nagainst placebo prior to becoming accepted in clinical practice. When \\nplacebo-controlled trials are eventually conducted, procedural interventions may \\nbe less effective than previously believed.\\nOBJECTIVE: To investigate the importance of including a placebo arm in trials of \\nsurgical and interventional procedures by comparing effect sizes from trials of \\nthe same procedure that do and do not include a placebo arm.\\nDATA SOURCES: Searches of MEDLINE and Embase identified all placebo-controlled \\ntrials for procedural interventions in any specialty of medicine and surgery \\nfrom inception to March 31, 2019. A secondary search identified randomized \\nclinical trials assessing the same intervention, condition, and end point but \\nwithout a placebo arm for paired comparison.\\nSTUDY SELECTION: Placebo-controlled trials of anatomically site-specific \\nprocedures requiring skin incision or endoscopic techniques were eligible for \\ninclusion; these were then matched to trials without placebo control that fell \\nwithin prespecified limits of heterogeneity.\\nDATA EXTRACTION AND SYNTHESIS: Random-effects meta-regression, with placebo and \\nblinding as a fixed effect and intervention and end point grouping as random \\neffects, was used to calculate the impact of placebo control for each end point.'), Document(page_content='blinding as a fixed effect and intervention and end point grouping as random \\neffects, was used to calculate the impact of placebo control for each end point. \\nData were analyzed from March 2019 to March 2020.\\nMAIN OUTCOMES AND MEASURES: End points were examined in prespecified subgroups: \\npatient-reported or health care professional-assessed outcomes, quality of life, \\npain, blood pressure, exercise-related outcomes, recurrent bleeding, and \\nall-cause mortality.\\nRESULTS: Ninety-seven end points were matched from 72 blinded, \\nplacebo-controlled trials (hereafter, blinded) and 55 unblinded trials without \\nplacebo control (hereafter, unblinded), including 111\\u202f500 individual patient end \\npoints. Unblinded trials had larger standardized effect sizes than blinded \\ntrials for exercise-related outcomes (standardized mean difference [SMD], 0.59; \\n95% CI, 0.29 to 0.89; P\\u2009<\\u2009.001) and quality-of-life (SMD, 0.32; 95% CI, 0.11 to \\n0.53; P\\u2009=\\u2009.003) and health care professional-assessed end points (SMD, 0.40; 95%'), Document(page_content='0.53; P\\u2009=\\u2009.003) and health care professional-assessed end points (SMD, 0.40; 95% \\nCI, 0.18 to 0.61; P\\u2009<\\u2009.001). The placebo effect accounted for 88.1%, 55.2%, and \\n61.3% of the observed unblinded effect size for these end points, respectively. \\nThere was no significant difference between unblinded and blinded trials for \\npatient-reported end points (SMD, 0.31; 95% CI, -0.02 to 0.64; P\\u2009=\\u2009.07), blood \\npressure (SMD, 0.26; 95% CI, -0.10 to 0.62; P\\u2009=\\u2009.15), all-cause mortality (odds \\nratio [OR], 0.23; 95% CI, -0.26 to 0.72; P\\u2009=\\u2009.36), pain (SMD, 0.03; 95% CI, \\n-0.52 to 0.57; P\\u2009=\\u2009.91), or recurrent bleeding events (OR, -0.12; 95% CI, -1.11 \\nto 0.88; P\\u2009=\\u2009.88).'), Document(page_content='to 0.88; P\\u2009=\\u2009.88).\\nCONCLUSIONS AND RELEVANCE: The magnitude of the placebo effect found in this \\nsystematic review and meta-regression was dependent on the end point. Placebo \\ncontrol in trials of procedural interventions had the greatest impact on \\nexercise-related, quality-of-life, and health care professional-assessed end \\npoints. Randomized clinical trials of procedural interventions may consider \\nplacebo control accordingly.'), Document(page_content='DOI: 10.1001/jamasurg.2024.0718\\nPMID: 386304621. Vet Res Commun. 2024 Apr 17. doi: 10.1007/s11259-024-10378-0. Online ahead of \\nprint.\\n\\nThe vehicle of administration, feed or water, and prandial state influence the \\noral bioavailability of amoxicillin in piglets.\\n\\nDecundo JM(1)(2), Dieguez SN(3)(4)(5), Martínez G(3)(4), Amanto FA(6), Gaudio \\nDSP(3)(4), Soraci AL(3)(4).'), Document(page_content='Author information:\\n(1)Laboratorio de Toxicología, Departamento de Fisiopatología, Facultad de \\nCiencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos \\nAires, Tandil, Argentina. jdecundo@vet.unicen.edu.ar.\\n(2)Facultad de Ciencias Veterinarias, Centro de Investigación Veterinaria de \\nTandil (CIVETAN, UNCPBA-CICPBA-CONICET), Paraje Arroyo Seco s/n, Campus \\nUniversitario, CP (7000), Tandil, Buenos Aires, Argentina. \\njdecundo@vet.unicen.edu.ar.\\n(3)Laboratorio de Toxicología, Departamento de Fisiopatología, Facultad de \\nCiencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos \\nAires, Tandil, Argentina.\\n(4)Facultad de Ciencias Veterinarias, Centro de Investigación Veterinaria de'), Document(page_content='Aires, Tandil, Argentina.\\n(4)Facultad de Ciencias Veterinarias, Centro de Investigación Veterinaria de \\nTandil (CIVETAN, UNCPBA-CICPBA-CONICET), Paraje Arroyo Seco s/n, Campus \\nUniversitario, CP (7000), Tandil, Buenos Aires, Argentina.\\n(5)Comisión de Investigaciones Científicas de la Provincia de Buenos Aires \\n(CIC-PBA), Tandil, Argentina.\\n(6)Área de Producción Porcina, Departamento de Producción Animal, Facultad de \\nCiencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos \\nAires, Tandil, Argentina.'), Document(page_content=\"Feed and water components may interact with drugs and affect their dissolution \\nand bioavailability. The impact of the vehicle of administration (feed and \\nwater) and the prandial condition of weaner piglets on amoxicillin´s oral \\nbioavailability was evaluated. First, amoxicillin's in vitro dissolution and \\nstability in purified, soft, and hard water, as well as release kinetics from \\nfeed in simulated gastric and intestinal media were assessed. Then, \\npharmacokinetic parameters and bioavailability were determined in fasted and fed \\npigs using soft water, hard water, or feed as vehicles of administration \\nfollowing a balanced incomplete block design. Amoxicillin showed similar \\ndissolution profiles in soft and hard water, distinct from the dissolution \\nprofile obtained with purified water. Complete dissolution was only achieved in \\npurified water, and merely reached 50% in soft or hard water. Once dissolved, \\nantibiotic concentrations decreased by around 20% after 24\\xa0h in all solutions. \\nKorsmeyer-Peppas model best described amoxicillin release from feed in simulated \\ngastric and intestinal media. Feed considerably reduced antibiotic dissolution \\nin both simulated media. In vivo, amoxicillin exhibited significantly higher \\nbioavailability when delivered via water to fasted than to fed animals, while\"), Document(page_content='gastric and intestinal media. Feed considerably reduced antibiotic dissolution \\nin both simulated media. In vivo, amoxicillin exhibited significantly higher \\nbioavailability when delivered via water to fasted than to fed animals, while \\nin-feed administration yielded the lowest values. All treatments showed a \\nsimilar rate of drug absorption. In conclusion, we demonstrated that water and \\nfeed components, as well as feed present in gastrointestinal tract of piglets \\ndecrease amoxicillin´s oral bioavailability. Therefore, the use of oral \\namoxicillin as a broad-spectrum antibiotic to treat systemic infections in pigs \\nshould be thoroughly revised.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer Nature B.V.\\n\\nDOI: 10.1007/s11259-024-10378-0\\nPMID: 386304261. Vet Res Commun. 2024 Apr 17. doi: 10.1007/s11259-024-10370-8. Online ahead of \\nprint.\\n\\nA case report of acute claudication due to vena cava thromboembolism in a dog \\nnaturally infected with Leishmania Infantum.\\n\\nCalvo-Sánchez N(#)(1), Gómez Á(#)(1), Pérez E(1), Borobia M(2), Luján L(1), \\nFernández A(1)(3)(4), Villanueva-Saz S(5)(6)(7), Verde M(1)(3)(4), Marteles \\nD(1)(3).'), Document(page_content='Author information:\\n(1)Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain.\\n(2)Veterinary Faculty, Veterinary Teaching Hospital, University of Zaragoza, \\nZaragoza, 50013, Spain.\\n(3)Clinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain.\\n(4)Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), \\nZaragoza, 50013, Spain.\\n(5)Department of Animal Pathology, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain. svs@unizar.es.\\n(6)Clinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, \\nZaragoza, 50013, Spain. svs@unizar.es.\\n(7)Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), \\nZaragoza, 50013, Spain. svs@unizar.es.\\n(#)Contributed equally'), Document(page_content='Canine leishmaniosis is a vector-borne disease caused by Leishmania infantum, \\nand clinical manifestations of infection range from absent or severe to fatal \\nand result from immune-mediated mechanisms. In dogs, the most common clinical \\nsigns of leishmaniosis include skin lesions and lymphadenomegaly. However, the \\npresence of other nontypical signs has been described, and diagnosing these \\ncases can be challenging. The aim of the present short communication was to \\ndescribe the impact of the formation of circulating immunocomplexes due to L. \\ninfantum in a dog with leishmaniosis affected by a massive venous thrombus of \\nthe caudal vena cava and external iliac veins. On admission, the dog presented \\nbilateral cutaneous vasculopathy of the thigh and renal disease due to L. \\ninfantum infection. Two weeks after starting anti-Leishmania treatment based on \\nmeglumine antimoniate and allopurinol administration, the animal developed acute \\nclaudication of the hind limbs with the presence of a thrombus in the caudal \\nvena cava and the external iliac veins and a high level of circulating \\nimmunocomplexes detected by enzyme-linked immunosorbent assay. Exacerbation of'), Document(page_content='vena cava and the external iliac veins and a high level of circulating \\nimmunocomplexes detected by enzyme-linked immunosorbent assay. Exacerbation of \\nthe humoral immune response, along with deposition of circulating immune \\ncomplexes in the tissues and the concurrent presence of kidney and liver damage, \\nmight have contributed to an imbalance in haemostasis in this patient. Future \\nstudies should evaluate and analyse the pathological mechanisms contributing to \\nthrombosis in dogs with leishmaniosis.'), Document(page_content=\"© 2024. The Author(s).\\n\\nDOI: 10.1007/s11259-024-10370-8\\nPMID: 386304251. J Clin Immunol. 2024 Apr 17;44(4):101. doi: 10.1007/s10875-024-01709-6.\\n\\nInborn Errors of Immunity in Jordan: First Report from a Tertiary Referral \\nCenter.\\n\\nAlzyoud R(1), Alsuweiti M(2), Maaitah H(2), Aladaileh B(2), Noubani M(2), Nsour \\nH(2).\\n\\nAuthor information:\\n(1)Pediatric Allergy, Immunology, and Rheumatology Division, Queen Rania \\nChildren's Hospital, Jordanian Royal Medical Service, Amman, Jordan. \\nraedalzyoud@gmail.com.\\n(2)Pediatric Allergy, Immunology, and Rheumatology Division, Queen Rania \\nChildren's Hospital, Jordanian Royal Medical Service, Amman, Jordan.\"), Document(page_content=\"PURPOSE: Inborn errors of immunity (IEI) are a heterogeneous group of diseases \\nwith variable clinical phenotypes. This study was conducted to describe the \\nepidemiology, clinical presentations, treatment, and outcome of IEI in Jordanian \\nchildren.\\nMETHODS: A retrospective data analysis was conducted for children under 15 years \\ndiagnosed with IEI from the pediatric Allergy, Immunology, and Rheumatology \\nDivision-based registry at Queen Rania Children's Hospital, Amman, Jordan, \\nbetween 2010 and 2022.\\nRESULTS: A total of 467 patients, 263 (56.3%) males and 204 (43.7%) females, \\nwere diagnosed with IEI. The mean age at symptom onset was 18 months (1 week to \\n144 months), a positive family history of IEI was reported in 43.5%, and the \\nconsanguinity rate was 47.9%. The most common IEI category was \\nimmunodeficiencies affecting cellular and humoral immunity at 33.2%, followed by \\npredominantly antibody deficiencies at 16.9%. The overall median diagnostic \\ndelay (range) was 6 (0-135) months; patients with a positive family history of \\nIEI had a statistically significant shorter diagnostic delay. Pulmonary and\"), Document(page_content='delay (range) was 6 (0-135) months; patients with a positive family history of \\nIEI had a statistically significant shorter diagnostic delay. Pulmonary and \\ngastrointestinal clinical features were the most common at 55.2% and 45.6%, \\nrespectively. The overall mortality was 33.2%; the highest rate was reported in \\nsevere combined immunodeficiency at 56.2%.\\nCONCLUSIONS: The high minimal estimated IEI prevalence at 16.2/100,000 Jordanian \\nchildren compared to the regional and worldwide data, with the diversities in \\nclinical presentation and distribution of IEI categories in our cohort point to \\nunique features of IEI in Jordanian children, call for national registry \\nestablishment, regional and international collaborative networks.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s10875-024-01709-6\\nPMID: 386304131. Neuroinformatics. 2024 Apr 17. doi: 10.1007/s12021-024-09663-9. Online ahead\\nof  print.\\n\\nGrowth-Associated Protein\\xa043 and Tensor-Based Morphometry Indices in Mild \\nCognitive Impairment.\\n\\nSeyedmirzaei H(1), Salmannezhad A(#)(2), Ashayeri H(#)(3), Shushtari A(#)(4), \\nFarazinia B(5), Heidari MM(6), Momayezi A(7), Shaki Baher S(8).'), Document(page_content='Author information:\\n(1)Sports Medicine Research Center, Neuroscience Institute, Tehran University of \\nMedical Sciences, Tehran, Iran.\\n(2)Student Research Committee, Ghazvin University of Medical Sciences, Ghazvin, \\nIran.\\n(3)Student Research Committee, Tabriz University of Medical Sciences, Tabriz, \\nIran.\\n(4)Faculty of Medicine , Mazandaran University of Medical Sciences, Sari, Iran. \\nalishoushtari1377@gmail.com.\\n(5)Faculty of Economics and Management, Shiraz Branch, Islamic Azad University, \\nShiraz, Iran.\\n(6)Student Research Committee, Faculty of Medicine, Kashan University of Medical \\nSciences, Kashan, Iran.\\n(7)School of Chemical engineering, Iran University of Science and Technology, \\nTehran, Iran.\\n(8)Faculty of Medicine, Tehran Branch, Islamic Azad University, Tehran, Iran.\\n(#)Contributed equally'), Document(page_content=\"Growth-associated protein 43 (GAP-43) is found in the axonal terminal of neurons \\nin the limbic system, which is affected in people with Alzheimer's disease (AD). \\nWe assumed GAP-43 may contribute to AD progression and serve as a biomarker. So, \\nin a two-year follow-up study, we assessed GAP-43 changes and whether they are \\ncorrelated with tensor-based morphometry (TBM) findings in patients with mild \\ncognitive impairment (MCI). We included MCI and cognitively normal (CN) people \\nwith available baseline and follow-up cerebrospinal fluid (CSF) GAP-43 and TBM \\nfindings from the ADNI database. We assessed the difference between the two \\ngroups and correlations in each group at each time point. CSF GAP-43 and TBM \\nmeasures were similar in the two study groups in all time points, except for the \\naccelerated anatomical region of interest (ROI) of CN subjects that were \\nsignificantly greater than those of MCI. The only significant correlations with \\nGAP-43 observed were those inverse correlations with accelerated and \\nnon-accelerated anatomical ROI in MCI subjects at baseline. Plus, all TBM \\nmetrics decreased significantly in all study groups during the follow-up in\"), Document(page_content='non-accelerated anatomical ROI in MCI subjects at baseline. Plus, all TBM \\nmetrics decreased significantly in all study groups during the follow-up in \\ncontrast to CSF GAP-43 levels. Our study revealed significant associations \\nbetween CSF GAP-43 levels and TBM indices among people of the AD spectrum.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s12021-024-09663-9\\nPMID: 386304111. Immunol Res. 2024 Apr 17. doi: 10.1007/s12026-024-09480-x. Online ahead of \\nprint.\\n\\nβ-Indole-3-acetic acid attenuated collagen-induced arthritis through reducing \\nthe ubiquitination of Foxp3 via the AhR-TAZ-Tip60 pathway.\\n\\nSu X(1), Wang X(2), Zhang X(2), Sun Y(1), Jia Y(3)(4).'), Document(page_content='Su X(1), Wang X(2), Zhang X(2), Sun Y(1), Jia Y(3)(4).\\n\\nAuthor information:\\n(1)Department of Chinese Medicine, Hebei University of Chinese Medicine, \\nShijiazhuang, 050200, China.\\n(2)Department of Integrative Chinese and Western Medicine, Hebei University of \\nChinese Medicine, Shijiazhuang, 050200, China.\\n(3)Department of Pharmacology, Hebei University of Chinese Medicine, \\nShijiazhuang, 050200, China. jiayugaihb@163.com.\\n(4)Hebei International Cooperation Center for Ion Channel Function and \\nInnovative Traditional Chinese Medicine, Shijiazhuang, 050091, China. \\njiayugaihb@163.com.'), Document(page_content='Massive evidence shows that intestinal tryptophan metabolites affected by \\nintestinal flora can modulate the progression of rheumatoid arthritis (RA). \\nHowever, the effects and mechanisms of intestinal tryptophan metabolites on RA \\nare not yet detailed. Herein, we investigated the protective effects of \\nintestinal tryptophan metabolites on RA and its detailed mechanisms. In this \\nstudy, the collagen-induced arthritis (CIA) rat model was established. Based on \\nmetabolomics analysis, the contents of β-indole-3-acetic acid (IAA), \\nindolylpropionic acid, and indole-3-β-acrylic acid in the sera of CIA rats were \\nsignificantly less compared with those of the normal rats. Under the condition \\nof Treg or Th17 cell differentiation, IAA significantly promoted the \\ndifferentiation and activation of Treg cells instead of Th17 cells. Intestinal \\ntryptophan metabolites are well-known endogenic ligands of aryl hydrocarbon \\nreceptor (AhR). Not surprisingly, IAA increased the level of Foxp3 through \\nactivating the AhR pathway. Interestingly, IAA had little impact on the level of \\nFoxp3 mRNA, but reducing the ubiquitination and degradation of Foxp3.'), Document(page_content='activating the AhR pathway. Interestingly, IAA had little impact on the level of \\nFoxp3 mRNA, but reducing the ubiquitination and degradation of Foxp3. \\nMechanically, IAA reduced the expression of the transcriptional coactivator TAZ, \\nwhich was almost completely reversed by either AhR antagonist CH223191 or siRNA. \\nIn vitro, IAA decreased the combination of TAZ and the histone acetyltransferase \\nTip60, while it increased the combination of Tip60 and Foxp3. In CIA rats, oral \\nadministration of IAA increased the number of Treg cells and relieved the \\ninflammation. A combined use with CH223191 almost abolished the effect of IAA. \\nTaken together, IAA attenuated CIA by promoting the differentiation of Treg \\ncells through reducing the ubiquitination of Foxp3 via the AhR-TAZ-Tip60 \\npathway.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s12026-024-09480-x\\nPMID: 386304081. Environ Sci Pollut Res Int. 2024 Apr 17. doi: 10.1007/s11356-024-33268-z.\\nOnline  ahead of print.\\n\\nAssociation between urinary BTEX metabolites and dyslexic odds among school-aged \\nchildren.\\n\\nLiu R(#)(1), Wan Y(#)(2), Zhu B(3), Liu Q(1), Wang H(1), Jiang Q(1), Feng Y(1), \\nZhu K(1), Zhao S(1), Xiang Z(1), Zhu Y(4), Song R(5).'), Document(page_content='Author information:\\n(1)Department of Maternal and Child Health and MOE (Ministry of Education) Key \\nLab of Environment and Health, School of Public Health, Tongji Medical College, \\nHuazhong University of Science and Technology, No 13 Hangkong Road, Wuhan, \\n430030, Hubei, China.\\n(2)Center for Public Health Laboratory Service, Institute of Environmental \\nHealth, Wuhan Centers for Disease Control & Prevention, Wuhan, 430024, Hubei, \\nChina.\\n(3)Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, \\n310051, China.\\n(4)Department of Epidemiology and Biostatistics, School of Public Health, Wuhan \\nUniversity, Wuhan, 430072, China.\\n(5)Department of Maternal and Child Health and MOE (Ministry of Education) Key \\nLab of Environment and Health, School of Public Health, Tongji Medical College, \\nHuazhong University of Science and Technology, No 13 Hangkong Road, Wuhan, \\n430030, Hubei, China. songranran@hust.edu.cn.\\n(#)Contributed equally'), Document(page_content='Benzene, toluene, ethylbenzene, and xylene (BTEX) are ubiquitous in the \\nenvironment, and all of them can cause neurotoxicity. However, the association \\nbetween BTEX exposure and dyslexia, a disorder with language network-related \\nregions in left hemisphere affected, remains unclear. We aimed to assess the \\nrelationship between BTEX exposure and dyslexic odds among school-aged children. \\nA case-control study, including 355 dyslexics and 390 controls from three cities \\nin China, was conducted. Six BTEX metabolites were measured in their\\xa0urine \\nsamples. Logistic regression model was used to explore the association between \\nthe\\xa0BTEX metabolites and the dyslexic odds. Urinary trans,trans-muconic acid \\n(MU: a metabolite of benzene) was significantly associated with an increased \\ndyslexic odds [odds ratio (OR)\\u2009=\\u20091.23, 95% confidence interval (CI): 1.01, \\n1.50], and the adjusted OR of the\\xa0dyslexic odds in the third tertile was 1.72 \\n(95% CI: 1.06, 2.77) compared to that in the lowest tertile regarding urinary MU \\nconcentration. Furthermore, the association between urinary MU level and'), Document(page_content='(95% CI: 1.06, 2.77) compared to that in the lowest tertile regarding urinary MU \\nconcentration. Furthermore, the association between urinary MU level and \\nthe\\xa0dyslexic odds was more pronounced among children from low-income families \\nbased on stratified analyses. Urinary metabolite levels of toluene, \\nethylbenzene, and xylene were not found to be\\xa0associated with the dyslexic odds. \\nIn summary, elevated MU concentrations may be associated with an increased \\ndyslexic odds. We should take measures to reduce MU related exposure among \\nchildren, particularly those with low family income.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \\npart of Springer Nature.\\n\\nDOI: 10.1007/s11356-024-33268-z\\nPMID: 386304001. Int J Clin Oncol. 2024 Apr 17. doi: 10.1007/s10147-024-02521-3. Online ahead\\nof  print.\\n\\nNew therapeutic target molecules for gastric and gastroesophageal junction \\ncancer.\\n\\nKawakami H(1).\\n\\nAuthor information:\\n(1)Department of Medical Oncology, Kindai University Faculty of Medicine, 377-2 \\nOhno-higashi, Osaka-sayama, 589-8511, Japan. kawakami_h@med.kindai.ac.jp.'), Document(page_content='Molecularly targeted therapy for receptor tyrosine kinases (RTKs) has faced \\nlimitations in gastric and gastroesophageal junction (G/GEJ) cancer except for \\nHER2-targeted agents, possibly due to inappropriate assay selection that has \\nhindered identification of sensitive patients, in addition to coexisting genetic \\nabnormalities as well as intratumoral heterogeneity. Immunohistochemistry of \\nRTKs has, thus, proved largely unsuccessful for patient selection, and detection \\nof RTK gene amplification as a true oncogenic driver is problematic given the \\nsmall numbers of affected individuals. FGFR2 amplification is associated with \\npoor prognosis in G/GEJ cancer, and immunohistochemistry of the FGFR2b protein \\nisoform has proved effective for the detection of such FGFR2-dependent tumors. \\nPhase III and Ib/III trials of the FGFR2-targeted antibody bemarituzumab for \\nG/GEJ cancer overexpressing FGFR2b are ongoing based on the promising result in \\na phase II trial, especially in cases with an FGFR2b positivity of\\u2009≥\\u200910%. \\nChallenges to EGFR- and MET-targeted therapies are being tackled with'), Document(page_content='a phase II trial, especially in cases with an FGFR2b positivity of\\u2009≥\\u200910%. \\nChallenges to EGFR- and MET-targeted therapies are being tackled with \\nantibody-drug conjugates (ADCs) and bispecific antibodies. CLDN18.2 is expressed \\nin some G/GEJ tumors but lacks oncogenic driver potential, and the \\nCLDN18.2-targeted antibody zolbetuximab prolonged the survival of \\nCLDN18.2-positive G/GEJ cancer patients in phase III trials. Antibody-drug \\nconjugates and ADCs that target CLDN18.2 are also being pursued for treatment of \\nsuch patients. Similarly, targeting of nondriver molecules such as DKK1, TROP2, \\nand CEACAM5 is under investigation in early-stage clinical trials. This shift in \\nfocus from target molecules with driver potential to markers for precise drug \\ndelivery should increase the number of possible targets in G/GEJ cancer.'), Document(page_content='© 2024. The Author(s) under exclusive licence to Japan Society of Clinical \\nOncology.\\n\\nDOI: 10.1007/s10147-024-02521-3\\nPMID: 386303831. Clin Oral Investig. 2024 Apr 17;28(5):253. doi: 10.1007/s00784-024-05631-4.\\n\\nLongevity of composite restorations in posterior teeth placed by dental \\nstudents: a 12-year retrospective study.\\n\\nAlonso ALL(1), Tirapelli C(2), Cruvinel PB(2), Cerqueira NM(1), Miranda CS(3), \\nCorona SAM(1), Souza-Gabriel AE(4).'), Document(page_content='Author information:\\n(1)Department of Restorative Dentistry, School of Dentistry of Ribeirão Preto, \\nUniversity of São Paulo, Av. do Café s/n, Ribeirão Preto, São Paulo, 14040-904, \\nBrazil.\\n(2)Department of Dental Materials and Prosthodontics, School of Dentistry of \\nRibeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.\\n(3)Department of Accounting, School of Economics, Business and Accounting of \\nUniversity of São Paulo, Ribeirão Preto, Brazil.\\n(4)Department of Restorative Dentistry, School of Dentistry of Ribeirão Preto, \\nUniversity of São Paulo, Av. do Café s/n, Ribeirão Preto, São Paulo, 14040-904, \\nBrazil. aline.gabriel@forp.usp.br.'), Document(page_content='OBJECTIVES: To evaluate the longevity of resin composite restorations placed in \\nposterior teeth by dental students, using data from electronic records from 2008 \\nto 2019.\\nMATERIALS AND METHODS: Demographic (gender and age) and clinical variables \\n(dental group, position in dental arch, and the number of restored surfaces) \\nwere evaluated. The 5-year follow-up was assessed according to the day the \\nrestoration was placed. Kaplan-Meier curves were generated to calculate the \\nannual failure rate. Data were analyzed by Chi-Square, Kruskal-Wallis, and \\nMann-Whitney tests (α\\u2009=\\u20090.05).\\nRESULTS: In total, 3.883 records relative to return periodicity were analyzed. \\nThe final sample consisted of 900 restorations from 479 patients. The majority \\nwere females, aged between 31 and 60. In total, 256 failures were reported \\n(success rate\\u2009=\\u200978%), showing an annual failure rate of 2.05%. The main reasons \\nfor failures were restoration replacement (55.5%), endodontics (21.9%), \\nprosthetics (14.5%) and extraction (8.2%). There was a higher risk of failure in'), Document(page_content='for failures were restoration replacement (55.5%), endodontics (21.9%), \\nprosthetics (14.5%) and extraction (8.2%). There was a higher risk of failure in \\nrestorations involving three or more surfaces (p\\u2009=\\u20090.000) and in patients over \\n60 years (p\\u2009<\\u20090.001). In females (p\\u2009=\\u20090.030), molars (p\\u2009=\\u20090.044), and maxillary \\nteeth (p\\u2009=\\u20090.038) failed in a shorter time.\\nCONCLUSIONS: Resin composite restorations placed in permanent posterior teeth by \\ndental students had high survival rates. The main reason for failure was the \\nreplacement of restorations. The age group and the number of restored surfaces \\nsignificantly affected the success of the restorations.\\nCLINICAL RELEVANCE: The electronic health records over 12 years showed that 78% \\nof the resin restorations in posterior teeth placed by dental students were \\nsuccessful for a minimum of five years.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \\npart of Springer Nature.\\n\\nDOI: 10.1007/s00784-024-05631-4\\nPMID: 386303761. World J Microbiol Biotechnol. 2024 Apr 17;40(6):164. doi: \\n10.1007/s11274-024-03981-5.\\n\\nHow does active yeast supplementation reduce the deleterious effects of \\naflatoxins in Wistar rats? A radiolabeled assay and histopathological study.\\n\\nSica P(1), Domingues MA(2), Mota LA(2), Pinto AU(2), Baptista AAS(3), Horii \\nJ(2), Abdalla AL(4), Baptista AS(2).'), Document(page_content='Author information:\\n(1)Department of Plant and Environmental Sciences, University of Copenhagen, 40 \\nThorvaldsenvej, Frederiksberg, 1870, Denmark. pietro@plen.ku.dk.\\n(2)Department of Agri-food Industry, Food and Nutrition, College of Agriculture \\n\"Luiz de Queiroz\", University of Sao Paulo\", Padua Dias Avenue, Piracicaba, Sao \\nPaulo, 13418-900, Brazil.\\n(3)Department of Preventive Veterinary Medicine, State University of Londrina, \\nLondrina, Parana, 86057-970, Brazil.\\n(4)Center for Nuclear Energy in Agriculture (CENA), University of Sao Paulo, \\n303, Centenario Avenue, Piracicaba, Sao Paulo, 13400-970, Brazil.'), Document(page_content='The aim of this study was to investigate the mechanisms by which yeasts \\n(Saccharomyces cerevisiae) control the toxic effects of aflatoxins, which are \\nnot yet fully understood. Radiolabeled aflatoxin B1 (AFB13H) was administered by \\ngavage to Wistar rats fed with aflatoxin (AflDiet) and aflatoxin supplemented \\nwith active dehydrated yeast Y904 (AflDiet\\u2009+\\u2009Yeast). The distribution of AFB13H \\nand its metabolites were analyzed at 24, 48 and 72\\xa0h by tracking back of the \\nradioactivity. No significant differences were observed between the AflDiet and \\nAflDiet\\u2009+\\u2009Yeast groups in terms of the distribution of labeled aflatoxin. At \\n72\\xa0h, for the AflDiet group the radiolabeled aflatoxin was distributed as \\nfollowing: feces (79.5%), carcass (10.5%), urine (1.7%), and intestine (7.4%); \\nin the AflDiet\\u2009+\\u2009Yeast the following distribution was observed: feces (76%), \\ncarcass (15%), urine (2.9%), and intestine (4.9%). These values were below 1% in'), Document(page_content='carcass (15%), urine (2.9%), and intestine (4.9%). These values were below 1% in \\nother organs. These findings indicate that even after 72\\xa0h considerable amounts \\nof aflatoxins remains in the intestines, which may play a significant role in \\nthe distribution and metabolism of aflatoxins and its metabolites over time. The \\npresence of yeast may not significantly affect this process. Furthermore, \\nhistopathological examination of hepatic tissues showed that the presence of \\nactive yeast reduced the severity of liver damage caused by aflatoxins, \\nindicating that yeasts control aflatoxin damage through biochemical mechanisms. \\nThese findings contribute to a better understanding of the mechanisms underlying \\nthe protective effects of yeasts against aflatoxin toxicity.'), Document(page_content=\"© 2024. The Author(s).\\n\\nDOI: 10.1007/s11274-024-03981-5\\nPMID: 386303731. Pharmacoecon Open. 2024 Apr 17. doi: 10.1007/s41669-024-00489-4. Online ahead\\nof  print.\\n\\nCost of Care for Non-communicable Diseases: Which Types of Healthcare Providers \\nare the Most Economical in India's Chhattisgarh State?\\n\\nGarg S(1), Tripathi N(2), Bebarta KK(2).\\n\\nAuthor information:\\n(1)State Health Resource Centre, Raipur, Chhattisgarh, India. koriya@gmail.com.\\n(2)State Health Resource Centre, Raipur, Chhattisgarh, India.\"), Document(page_content='BACKGROUND: Non-communicable diseases (NCDs) affect a large number of people \\nglobally and their burden has been growing. Healthcare for NCDs often involves \\nhigh out-of-pocket expenditure and rising costs of providing services. Financing \\nand providing care for NCDs have become a major challenge for health systems. \\nDespite the high burden of NCDs in India, there is little information available \\non the costs involved in NCD care.\\nMETHODS: The study was aimed at finding out the average monthly cost of \\noutpatient care per NCD patient. The average cost was defined as all resources \\nspent directly by government and citizens to get a month of care for a NCD \\npatient. The cost borne by the government on public facilities was taken into \\naccount and activity-based costing was used to apportion it to the function of \\nproviding outpatient NCD care. For robustness, time-driven activity-based \\ncosting and sensitivity analyses were also performed. The study was conducted in \\nChhattisgarh State and involved a household survey and a facility survey, \\nconducted simultaneously at the end of 2022. The surveys had a sample \\nrepresentative of the state, covering 3500 individuals above age of 30 years and \\n108 health facilities.'), Document(page_content='conducted simultaneously at the end of 2022. The surveys had a sample \\nrepresentative of the state, covering 3500 individuals above age of 30 years and \\n108 health facilities.\\nRESULTS: The average monthly cost per NCD patient was Indian Rupees (INR) 688 \\nfor public providers, INR 1389 for formal for-profit providers and INR 408 for \\ninformal private providers and they managed 53.5, 34.3 and 12.0% of NCD patients \\nrespectively. The disease profile of patients handled by different types of \\nproviders was similar. The average cost per patient was lowest for the primary \\ncare facilities in the public sector.\\nCONCLUSIONS: The average direct cost of NCD care for government and citizens put \\ntogether was substantially higher in case of formal for-profit providers \\ncompared with public facilities, even after taking into account the government \\nsubsidies to public sector. This has implications for allocative efficiency and \\nthe desired public-private provider mix in health systems.'), Document(page_content='© 2024. The Author(s).\\n\\nDOI: 10.1007/s41669-024-00489-4\\nPMID: 386303631. Mol Cell Biochem. 2024 Apr 17. doi: 10.1007/s11010-024-05001-4. Online ahead\\nof  print.\\n\\nValproate decreases transgenerationally blood pressure by affecting \\nthyrotropin-releasing hormone promoter DNA methylation and gene expression in \\nspontaneously hypertensive rat.\\n\\nLanda MS(1)(2), Schuman ML(1)(2), Aisicovich M(1)(2), Peres Diaz LS(1)(2), \\nGironacci MM(3), García SI(4)(5)(6), Pirola CJ(7)(8).'), Document(page_content='Author information:\\n(1)School of Medicine, Institute of Medical Research A. Lanari, Universidad de \\nBuenos Aires, Combatientes de Malvinas 3150, 1427, Ciudad Autonoma de Buenos \\nAires, Argentina.\\n(2)Department of Molecular Cardiology, Institute of Medical Research (IDIM), \\nNational Scientific and Technical Research Council (CONICET), Universidad de \\nBuenos Aires (UBA), Ciudad Autonoma de Buenos Aires, Argentina.\\n(3)Department of Biological Chemistry, Faculty of Pharmacy and Biochemistry, \\nSchool of Pharmacy and Biochemistry (IQUIFIB), National Scientific and Technical \\nResearch Council (CONICET), Universidad de Buenos Aires (UBA), Ciudad Autonoma \\nde Buenos Aires, Argentina.\\n(4)School of Medicine, Institute of Medical Research A. Lanari, Universidad de \\nBuenos Aires, Combatientes de Malvinas 3150, 1427, Ciudad Autonoma de Buenos \\nAires, Argentina. garcia.silvia@conicet.gov.ar.\\n(5)Department of Molecular Cardiology, Institute of Medical Research (IDIM), \\nNational Scientific and Technical Research Council (CONICET), Universidad de'), Document(page_content='(5)Department of Molecular Cardiology, Institute of Medical Research (IDIM), \\nNational Scientific and Technical Research Council (CONICET), Universidad de \\nBuenos Aires (UBA), Ciudad Autonoma de Buenos Aires, Argentina. \\ngarcia.silvia@conicet.gov.ar.\\n(6)Laboratory of Experimental Medicine, Hospital Alemán, Ciudad Autónoma de \\nBuenos Aires, Argentina. garcia.silvia@conicet.gov.ar.\\n(7)Department of Molecular Genetics and Biology of Complex Diseases, Center for \\nTraslational Research in Health, Maimonides University, Hidalgo 775, 1405, \\nCiudad Autonoma de Buenos Aires, Argentina. pirola.carlos@maimonides.edu.\\n(8)National Scientific and Technical Research Council (CONICET), Ciudad Autonoma \\nde Buenos Aires, Argentina. pirola.carlos@maimonides.edu.'), Document(page_content='Central TRH, a neuropeptide, is involved in cardiovascular regulation. We \\ndemonstrated that the overexpression of diencephalic TRH (dTRH) in SHR rats can \\nbe prevented by antisense treatment, normalizing blood pressure (BP). Valproate \\n(VPA) is an inhibitor of histone deacetylases (HDAC) which modulates gene \\nexpression through epigenetic modifications such as DNA methylation.\\nAIMS: Study the role of HDAC inhibition in the regulation of dTRH gene \\nexpression and its effect on the pathogenesis of hypertension.\\nMAIN METHODS: We treated 7-weeks-old male and female SHR and WKY rats with VPA \\nfor 10\\xa0weeks and evaluated BP, dTRH mRNA and methylation gene status.\\nKEY FINDINGS: VPA attenuated the elevated BP and dTRH mRNA expression \\ncharacteristic of SHR. Indeed, we found a significant 62% reduction in dTRH mRNA \\nexpression in the SHR\\u2009+\\u2009VPA group compared to control SHR. The decrease TRH mRNA \\nexpression induced by VPA was confirmed \"in vitro\" in a primary neuron culture \\nusing trichostatin A. With methylation specific PCR we demonstrated a'), Document(page_content='expression induced by VPA was confirmed \"in vitro\" in a primary neuron culture \\nusing trichostatin A. With methylation specific PCR we demonstrated a \\nsignificant increase in TRH promoter DNA methylation level in SHR\\u2009+\\u2009VPA group \\ncompared to control SHR. After 2\\xa0weeks of treatment interruption, rats were \\nmated. Although they did not receive any treatment, the offspring born from \\nVPA-treated SHR parents showed similar changes in BP, dTRH expression and \\nmethylation status, implying a transgenerational inheritance. Our findings \\nsuggest that dTRH modulation by epigenetics mechanism affects BP and could be \\ninherited by the next generation in SHR rats.'), Document(page_content='© 2024. The Author(s), under exclusive licence to Springer Science+Business \\nMedia, LLC, part of Springer Nature.\\n\\nDOI: 10.1007/s11010-024-05001-4\\nPMID: 38630362')]\n",
      "85\n"
     ]
    }
   ],
   "source": [
    "#Lets use the retriever to find relevant documents\n",
    "retrieved_docs= split_embeder_retrieve(output1['text'],question)\n"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:52:33.983443400Z",
     "start_time": "2024-04-17T18:52:26.659042200Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "outputs": [],
   "source": [
    "def format_docs(docs):\n",
    "    \"\"\"\n",
    "    creates a final document based on the relevant data\n",
    "    :param docs:\n",
    "    :return: document\n",
    "    \"\"\"\n",
    "    return \"\\n\\n\".join(doc.page_content for doc in docs)\n",
    "formatted_docs=format_docs(retrieved_docs)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:52:34.042567200Z",
     "start_time": "2024-04-17T18:52:34.005925300Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "outputs": [],
   "source": [
    "\"\"\"\n",
    "rag_chain takes in the question and context so that it can answer the question fully. It will output an article with a list of references.\n",
    "\"\"\"\n",
    "rag_chain =  prompt | llm | StrOutputParser()\n",
    "answer= rag_chain.invoke(\n",
    "        {\n",
    "            \"question\":question,\n",
    "            \"text\":formatted_docs\n",
    "        }\n",
    "    )"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:53:25.975219100Z",
     "start_time": "2024-04-17T18:52:34.026121400Z"
    }
   }
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "# The Impact of Exercise on Blood Glucose Levels: A Critical Analysis\n",
      "\n",
      "## Abstract\n",
      "\n",
      "Regular physical activity is widely acknowledged for its positive effects on overall health, and has been particularly associated with glucose metabolism regulation. The intricate relationship between exercise and blood glucose levels hinges on a set of physiological mechanisms that facilitate glucose transportation and utilization. While the provided information does not directly address the correlation between exercise and blood glucose levels, it does include data on the impact of exercise on other health-related outcomes, which may indirectly suggest benefits that could extend to glycemic control. This report aims to critically analyze available literature and data to elucidate how exercise affects blood glucose levels based on the given information and additional pertinent sources.\n",
      "\n",
      "## Introduction\n",
      "\n",
      "The prevalence of metabolic disorders, such as diabetes, has prompted extensive research into lifestyle modifications that can mitigate these conditions. Exercise is a cornerstone intervention recommended to maintain euglycemia – the state of having normal blood glucose levels. It is critical to explore how exercise influences blood glucose control and to understand the mechanisms behind this relationship. The onset of depression, often associated with chronic illnesses like diabetes, has been noted to potentially decrease with regular muscle-strengthening exercise, indicating a multifaceted benefit of physical activity. This report endeavors to examine the connection between exercise and blood glucose regulation in detail.\n",
      "\n",
      "## Materials and Methods\n",
      "\n",
      "To construct a comprehensive report, a cross-sectional analysis of scientific literature and clinical trial results was undertaken. Specifically, studies that addressed the impact of exercise on various health outcomes – including patient-reported outcomes, quality of life, and exercise-related outcomes – were reviewed. These past studies were identified from the provided information and related reputable databases, with a focus on how such outcomes could relate to blood glucose control.\n",
      "\n",
      "## Discussion\n",
      "\n",
      "### Physiological Mechanisms of Exercise on Glucose Metabolism\n",
      "\n",
      "Exercise influences blood glucose levels through multiple physiological mechanisms. During physical activity, muscle contractions increase the uptake of glucose from the bloodstream to be used as energy, thereby reducing blood glucose levels. This process is facilitated both by insulin-dependent and insulin-independent pathways. The latter is particularly important during exercise, as it allows muscles to utilize glucose effectively even in individuals with insulin sensitivity issues, such as those with type 2 diabetes.\n",
      "\n",
      "### Impact of Aerobic and Resistance Exercise on Glycemic Control\n",
      "\n",
      "Aerobic exercise, such as walking, running, and cycling, has been shown to enhance insulin sensitivity and promote glucose uptake by muscle cells. Resistance training, which involves activities like weight lifting, similarly improves glycemic control by increasing muscle mass – a key determinant in resting metabolic rate and insulin sensitivity.\n",
      "\n",
      "### Acute vs. Chronic Effects of Exercise on Glucose Levels\n",
      "\n",
      "The effects of exercise on blood glucose can be classified into acute (short-term) and chronic (long-term) adaptations. Acutely, exercise can lower blood glucose levels for several hours post-activity. Chronically, regular physical activity enhances the body’s ability to manage glucose effectively, thereby improving overall metabolic health and reducing the risk of hyperglycemia and diabetes.\n",
      "\n",
      "### Exercise Recommendations for Glycemic Control\n",
      "\n",
      "Current guidelines advocate for a combination of both aerobic and resistance training to achieve optimal glycemic control. The intensity and duration of exercise are tailored to individual fitness levels and metabolic goals, with the consensus pointing towards at least 150 minutes of moderate to vigorous aerobic exercise weekly, supplemented by resistance training on two or more days.\n",
      "\n",
      "### Analysis of Literature and Data\n",
      "\n",
      "While the presented information does not specifically address the effects of exercise on blood glucose, the positive outcome on exercise-related measures implies a likely favorable impact on glucose control. Quality-of-life improvements through physical activity further suggest an enhancement in metabolic conditions. The placebo-controlled trials cited offer an insight into how perceived benefits, in the absence of tangible interventions, can shift health outcomes – underscoring the importance of objectively measuring exercise’s effect on blood glucose.\n",
      "\n",
      "### Limitations\n",
      "\n",
      "The inherent limitations of the secondary data used for this report include the lack of direct measurements and outcomes specific to blood glucose regulation. Moreover, the inter-individual variabilities in exercise response and glycemic control necessitate personalized approaches to diabetes management and prevent broad generalizations from being made.\n",
      "\n",
      "## Conclusions\n",
      "\n",
      "This report underscores the critical role of exercise in the management and regulation of blood glucose levels, supported by physiological evidence and corroborated by broader health outcomes research. Although immediate data on exercise and blood glucose was not provided, the inference drawn from related health improvements suggests that regular, structured physical activity is a vital component of metabolic health strategies.\n",
      "\n",
      "## Recommendations\n",
      "\n",
      "1. Encourage the adoption of regular aerobic and resistance training regimes aimed at enhancing insulin sensitivity and glycemic control.\n",
      "2. Further research should directly correlate exercise types, frequencies, and intensities with changes in blood glucose levels in diverse populations.\n",
      "3. Health professionals should consider personalized exercise prescriptions to optimize metabolic health for individuals with or at risk of diabetes.\n",
      "\n",
      "## References\n",
      "\n",
      "The reference URLs provided in the initial information are included below as the primary sources for the content within our discussion:\n",
      "\n",
      "- JMIR Human Factors: https://humanfactors.jmir.org\n",
      "- JMIR Public Health Surveill: https://publichealth.jmir.org\n",
      "\n",
      "For the purposes of this report, data was extrapolated and supplemented with additional academic research and reputable sources to better assess the relationship between exercise and blood glucose management.\n",
      "\n",
      "## Acknowledgments\n",
      "\n",
      "The authors of the original research cited in the provided information are acknowledged for their contributions to the field of health outcomes and exercise-related research. \n",
      "\n",
      "This report is a result of an independent analysis and synthesizes the provided information with additional literature to form a comprehensive understanding of exercise's impact on blood glucose levels. The inferences and conclusions drawn are those of the report's authors and not necessarily reflective of the original authors' positions.\n"
     ]
    }
   ],
   "source": [
    "print(answer)"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-17T18:53:25.989420800Z",
     "start_time": "2024-04-17T18:53:25.976222400Z"
    }
   }
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
